WO2023216238A1 - Composition et son utilisation, et matériaux la comprenant - Google Patents
Composition et son utilisation, et matériaux la comprenant Download PDFInfo
- Publication number
- WO2023216238A1 WO2023216238A1 PCT/CN2022/092725 CN2022092725W WO2023216238A1 WO 2023216238 A1 WO2023216238 A1 WO 2023216238A1 CN 2022092725 W CN2022092725 W CN 2022092725W WO 2023216238 A1 WO2023216238 A1 WO 2023216238A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- weight
- composition
- mask
- present
- disinfectant
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 337
- 239000000463 material Substances 0.000 title claims abstract description 155
- 239000000758 substrate Substances 0.000 claims abstract description 23
- 239000000243 solution Substances 0.000 claims description 156
- 238000000034 method Methods 0.000 claims description 131
- 239000007864 aqueous solution Substances 0.000 claims description 90
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 82
- 150000001875 compounds Chemical class 0.000 claims description 75
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 73
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 64
- 229940024606 amino acid Drugs 0.000 claims description 53
- 235000001014 amino acid Nutrition 0.000 claims description 53
- 150000001413 amino acids Chemical class 0.000 claims description 53
- -1 cyclic enol compound Chemical class 0.000 claims description 53
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 49
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 47
- 235000018102 proteins Nutrition 0.000 claims description 44
- 102000004169 proteins and genes Human genes 0.000 claims description 44
- 239000003755 preservative agent Substances 0.000 claims description 43
- 108090000623 proteins and genes Proteins 0.000 claims description 43
- 239000007788 liquid Substances 0.000 claims description 41
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 38
- 229930003268 Vitamin C Natural products 0.000 claims description 38
- 235000019154 vitamin C Nutrition 0.000 claims description 38
- 239000011718 vitamin C Substances 0.000 claims description 38
- 239000004471 Glycine Substances 0.000 claims description 36
- 150000002085 enols Chemical group 0.000 claims description 36
- 229920000742 Cotton Polymers 0.000 claims description 31
- 239000000419 plant extract Substances 0.000 claims description 30
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 30
- 230000002335 preservative effect Effects 0.000 claims description 29
- 239000000872 buffer Substances 0.000 claims description 28
- 239000003795 chemical substances by application Substances 0.000 claims description 28
- 239000007921 spray Substances 0.000 claims description 28
- 239000000701 coagulant Substances 0.000 claims description 25
- 239000004744 fabric Substances 0.000 claims description 21
- 102000004190 Enzymes Human genes 0.000 claims description 20
- 108090000790 Enzymes Proteins 0.000 claims description 20
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical group CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims description 20
- 239000005667 attractant Substances 0.000 claims description 20
- 235000011187 glycerol Nutrition 0.000 claims description 20
- 238000002955 isolation Methods 0.000 claims description 19
- 125000000217 alkyl group Chemical group 0.000 claims description 16
- 230000031902 chemoattractant activity Effects 0.000 claims description 16
- 102000016938 Catalase Human genes 0.000 claims description 15
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 15
- 239000003995 emulsifying agent Substances 0.000 claims description 15
- 239000000565 sealant Substances 0.000 claims description 14
- 108010053835 Catalase Proteins 0.000 claims description 13
- 239000003963 antioxidant agent Substances 0.000 claims description 13
- 235000006708 antioxidants Nutrition 0.000 claims description 13
- 239000004615 ingredient Substances 0.000 claims description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- 230000000873 masking effect Effects 0.000 claims description 12
- 239000004745 nonwoven fabric Substances 0.000 claims description 12
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 11
- 239000006096 absorbing agent Substances 0.000 claims description 11
- 230000003078 antioxidant effect Effects 0.000 claims description 10
- 125000003118 aryl group Chemical group 0.000 claims description 10
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 10
- 125000005842 heteroatom Chemical group 0.000 claims description 9
- 229910052751 metal Inorganic materials 0.000 claims description 9
- 239000002184 metal Substances 0.000 claims description 9
- 238000005507 spraying Methods 0.000 claims description 9
- 229920000728 polyester Polymers 0.000 claims description 8
- 125000001424 substituent group Chemical group 0.000 claims description 8
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 7
- 229960003767 alanine Drugs 0.000 claims description 7
- 229960001153 serine Drugs 0.000 claims description 7
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims description 6
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 6
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 6
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 6
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 6
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 claims description 6
- WQABCVAJNWAXTE-UHFFFAOYSA-N dimercaprol Chemical compound OCC(S)CS WQABCVAJNWAXTE-UHFFFAOYSA-N 0.000 claims description 6
- 229960001051 dimercaprol Drugs 0.000 claims description 6
- 239000003365 glass fiber Substances 0.000 claims description 6
- 229930182478 glucoside Natural products 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 239000001540 sodium lactate Substances 0.000 claims description 6
- 235000011088 sodium lactate Nutrition 0.000 claims description 6
- 229940005581 sodium lactate Drugs 0.000 claims description 6
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims description 5
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 5
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical class OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 claims description 5
- 239000002202 Polyethylene glycol Substances 0.000 claims description 5
- 229930003761 Vitamin B9 Natural products 0.000 claims description 5
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- 235000018417 cysteine Nutrition 0.000 claims description 5
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 5
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 5
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 5
- 235000013922 glutamic acid Nutrition 0.000 claims description 5
- 239000004220 glutamic acid Substances 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- XLSMFKSTNGKWQX-UHFFFAOYSA-N hydroxyacetone Chemical class CC(=O)CO XLSMFKSTNGKWQX-UHFFFAOYSA-N 0.000 claims description 5
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 5
- 229920000570 polyether Polymers 0.000 claims description 5
- 229920001223 polyethylene glycol Polymers 0.000 claims description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 5
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 5
- 239000000600 sorbitol Substances 0.000 claims description 5
- 235000019158 vitamin B6 Nutrition 0.000 claims description 5
- 239000011726 vitamin B6 Substances 0.000 claims description 5
- 235000019159 vitamin B9 Nutrition 0.000 claims description 5
- 239000011727 vitamin B9 Substances 0.000 claims description 5
- 229940011671 vitamin b6 Drugs 0.000 claims description 5
- 239000000811 xylitol Substances 0.000 claims description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 5
- 229960002675 xylitol Drugs 0.000 claims description 5
- 235000010447 xylitol Nutrition 0.000 claims description 5
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims description 4
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 4
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 4
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 4
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 4
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 4
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 4
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 4
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 4
- 235000004279 alanine Nutrition 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 4
- 235000019136 lipoic acid Nutrition 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 239000011593 sulfur Chemical group 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- 229960002663 thioctic acid Drugs 0.000 claims description 4
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 claims description 4
- GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 claims description 3
- 239000004475 Arginine Substances 0.000 claims description 3
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 3
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 3
- 239000004472 Lysine Substances 0.000 claims description 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 3
- 239000004473 Threonine Substances 0.000 claims description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 3
- 125000002252 acyl group Chemical group 0.000 claims description 3
- 239000003570 air Substances 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims description 3
- 229960001230 asparagine Drugs 0.000 claims description 3
- 235000009582 asparagine Nutrition 0.000 claims description 3
- 235000003704 aspartic acid Nutrition 0.000 claims description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims description 3
- 239000011491 glass wool Substances 0.000 claims description 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 3
- 229960000310 isoleucine Drugs 0.000 claims description 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 3
- 229930182817 methionine Natural products 0.000 claims description 3
- 239000011490 mineral wool Substances 0.000 claims description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 3
- 229930003802 tocotrienol Natural products 0.000 claims description 3
- 239000011731 tocotrienol Substances 0.000 claims description 3
- 235000019148 tocotrienols Nutrition 0.000 claims description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 3
- 239000004474 valine Substances 0.000 claims description 3
- DVOOXRTYGGLORL-VKHMYHEASA-N (2r)-2-(methylamino)-3-sulfanylpropanoic acid Chemical compound CN[C@@H](CS)C(O)=O DVOOXRTYGGLORL-VKHMYHEASA-N 0.000 claims description 2
- LJRDOKAZOAKLDU-UDXJMMFXSA-N (2s,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-[(2r,3s,4r,5s)-5-[(1r,2r,3s,5r,6s)-3,5-diamino-2-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol;sulfuric ac Chemical compound OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO LJRDOKAZOAKLDU-UDXJMMFXSA-N 0.000 claims description 2
- 108030002440 Catalase peroxidases Proteins 0.000 claims description 2
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 claims description 2
- 108010024636 Glutathione Proteins 0.000 claims description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 2
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical group [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- YTGJWQPHMWSCST-UHFFFAOYSA-N Tiopronin Chemical compound CC(S)C(=O)NCC(O)=O YTGJWQPHMWSCST-UHFFFAOYSA-N 0.000 claims description 2
- 108010058907 Tiopronin Proteins 0.000 claims description 2
- 229940067599 ascorbyl glucoside Drugs 0.000 claims description 2
- 235000010350 erythorbic acid Nutrition 0.000 claims description 2
- 229960003180 glutathione Drugs 0.000 claims description 2
- 235000003969 glutathione Nutrition 0.000 claims description 2
- 229940026239 isoascorbic acid Drugs 0.000 claims description 2
- 239000004750 melt-blown nonwoven Substances 0.000 claims description 2
- 229960001639 penicillamine Drugs 0.000 claims description 2
- 229910052698 phosphorus Chemical group 0.000 claims description 2
- 239000011574 phosphorus Chemical group 0.000 claims description 2
- 229960004402 tiopronin Drugs 0.000 claims description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 2
- 150000003573 thiols Chemical class 0.000 claims 2
- 239000004318 erythorbic acid Substances 0.000 claims 1
- 235000019260 propionic acid Nutrition 0.000 claims 1
- 229940095574 propionic acid Drugs 0.000 claims 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims 1
- FGGPAWQCCGEWTJ-UHFFFAOYSA-M sodium;2,3-bis(sulfanyl)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(S)CS FGGPAWQCCGEWTJ-UHFFFAOYSA-M 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 239000003230 hygroscopic agent Substances 0.000 abstract description 6
- 239000003463 adsorbent Substances 0.000 abstract 1
- 239000000645 desinfectant Substances 0.000 description 266
- 238000012360 testing method Methods 0.000 description 114
- 239000007789 gas Substances 0.000 description 109
- 239000002585 base Substances 0.000 description 108
- 238000004448 titration Methods 0.000 description 90
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 76
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 76
- 239000000460 chlorine Substances 0.000 description 58
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 57
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 description 56
- 229910052801 chlorine Inorganic materials 0.000 description 55
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 54
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 48
- 230000001681 protective effect Effects 0.000 description 46
- 230000000694 effects Effects 0.000 description 44
- 238000002474 experimental method Methods 0.000 description 39
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 34
- 230000001590 oxidative effect Effects 0.000 description 34
- 239000000126 substance Substances 0.000 description 32
- 239000004155 Chlorine dioxide Substances 0.000 description 28
- 235000019398 chlorine dioxide Nutrition 0.000 description 28
- 239000000284 extract Substances 0.000 description 27
- 238000004659 sterilization and disinfection Methods 0.000 description 24
- 238000006243 chemical reaction Methods 0.000 description 23
- 229960004063 propylene glycol Drugs 0.000 description 22
- 238000001514 detection method Methods 0.000 description 20
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 18
- 230000008859 change Effects 0.000 description 18
- 239000004480 active ingredient Substances 0.000 description 17
- 241000894006 Bacteria Species 0.000 description 16
- 229960004308 acetylcysteine Drugs 0.000 description 16
- 230000035943 smell Effects 0.000 description 16
- YRIZYWQGELRKNT-UHFFFAOYSA-N 1,3,5-trichloro-1,3,5-triazinane-2,4,6-trione Chemical compound ClN1C(=O)N(Cl)C(=O)N(Cl)C1=O YRIZYWQGELRKNT-UHFFFAOYSA-N 0.000 description 14
- 239000002253 acid Substances 0.000 description 14
- 230000000813 microbial effect Effects 0.000 description 14
- 230000001603 reducing effect Effects 0.000 description 14
- 238000001179 sorption measurement Methods 0.000 description 14
- 229950009390 symclosene Drugs 0.000 description 14
- 244000005700 microbiome Species 0.000 description 13
- 239000005708 Sodium hypochlorite Substances 0.000 description 12
- 239000013543 active substance Substances 0.000 description 12
- 239000002245 particle Substances 0.000 description 12
- 238000007789 sealing Methods 0.000 description 12
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 12
- 230000001815 facial effect Effects 0.000 description 11
- 238000003860 storage Methods 0.000 description 11
- 150000001299 aldehydes Chemical class 0.000 description 10
- 239000002973 irritant agent Substances 0.000 description 10
- 239000011259 mixed solution Substances 0.000 description 10
- 230000003472 neutralizing effect Effects 0.000 description 10
- 150000002978 peroxides Chemical class 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 238000010438 heat treatment Methods 0.000 description 9
- 239000008363 phosphate buffer Substances 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical group [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 238000001704 evaporation Methods 0.000 description 8
- 238000003958 fumigation Methods 0.000 description 8
- 235000002532 grape seed extract Nutrition 0.000 description 8
- 229910052740 iodine Inorganic materials 0.000 description 8
- 239000011630 iodine Substances 0.000 description 8
- 238000006386 neutralization reaction Methods 0.000 description 8
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 7
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 7
- 241000233866 Fungi Species 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 7
- 125000004432 carbon atom Chemical group C* 0.000 description 7
- 229940087603 grape seed extract Drugs 0.000 description 7
- 230000017525 heat dissipation Effects 0.000 description 7
- 230000007794 irritation Effects 0.000 description 7
- 229920003023 plastic Polymers 0.000 description 7
- 238000001556 precipitation Methods 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- 238000009877 rendering Methods 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 239000001717 vitis vinifera seed extract Substances 0.000 description 7
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
- 108010000912 Egg Proteins Proteins 0.000 description 6
- 102000002322 Egg Proteins Human genes 0.000 description 6
- 235000014103 egg white Nutrition 0.000 description 6
- 210000000969 egg white Anatomy 0.000 description 6
- 239000008098 formaldehyde solution Substances 0.000 description 6
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 6
- 229940057995 liquid paraffin Drugs 0.000 description 6
- 230000004952 protein activity Effects 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 6
- 229940001584 sodium metabisulfite Drugs 0.000 description 6
- 235000010262 sodium metabisulphite Nutrition 0.000 description 6
- 239000013589 supplement Substances 0.000 description 6
- LEAHFJQFYSDGGP-UHFFFAOYSA-K trisodium;dihydrogen phosphate;hydrogen phosphate Chemical group [Na+].[Na+].[Na+].OP(O)([O-])=O.OP([O-])([O-])=O LEAHFJQFYSDGGP-UHFFFAOYSA-K 0.000 description 6
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 5
- 241000700605 Viruses Species 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 238000009529 body temperature measurement Methods 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 238000004925 denaturation Methods 0.000 description 5
- 230000036425 denaturation Effects 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 238000002845 discoloration Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000009322 erkang Substances 0.000 description 5
- 235000012209 glucono delta-lactone Nutrition 0.000 description 5
- 239000000182 glucono-delta-lactone Substances 0.000 description 5
- 229960003681 gluconolactone Drugs 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000011056 performance test Methods 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000000241 respiratory effect Effects 0.000 description 5
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 235000019501 Lemon oil Nutrition 0.000 description 4
- 102000018697 Membrane Proteins Human genes 0.000 description 4
- 108010052285 Membrane Proteins Proteins 0.000 description 4
- 206010073310 Occupational exposures Diseases 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000000840 anti-viral effect Effects 0.000 description 4
- 230000000975 bioactive effect Effects 0.000 description 4
- 239000006172 buffering agent Substances 0.000 description 4
- 229920002770 condensed tannin Polymers 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 239000010419 fine particle Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 229910001385 heavy metal Inorganic materials 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 239000010501 lemon oil Substances 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 210000004400 mucous membrane Anatomy 0.000 description 4
- 239000012299 nitrogen atmosphere Substances 0.000 description 4
- 230000000474 nursing effect Effects 0.000 description 4
- 231100000675 occupational exposure Toxicity 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 4
- 229920000053 polysorbate 80 Polymers 0.000 description 4
- ALDITMKAAPLVJK-UHFFFAOYSA-N prop-1-ene;hydrate Chemical group O.CC=C ALDITMKAAPLVJK-UHFFFAOYSA-N 0.000 description 4
- 210000002345 respiratory system Anatomy 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 4
- 235000019345 sodium thiosulphate Nutrition 0.000 description 4
- 229960002920 sorbitol Drugs 0.000 description 4
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 3
- 241000245240 Lonicera Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229920001991 Proanthocyanidin Polymers 0.000 description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 125000002619 bicyclic group Chemical group 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000000249 desinfective effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000428 dust Substances 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 3
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical group CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000002949 hemolytic effect Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 3
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 3
- 235000009498 luteolin Nutrition 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000006479 redox reaction Methods 0.000 description 3
- 210000001533 respiratory mucosa Anatomy 0.000 description 3
- 125000006413 ring segment Chemical group 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000001568 sexual effect Effects 0.000 description 3
- WVTKBKWTSCPRNU-KYJUHHDHSA-N (+)-Tetrandrine Chemical compound C([C@H]1C=2C=C(C(=CC=2CCN1C)OC)O1)C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@@H]2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-KYJUHHDHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- 241000675108 Citrus tangerina Species 0.000 description 2
- 102100031673 Corneodesmosin Human genes 0.000 description 2
- 101710139375 Corneodesmosin Proteins 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 239000001263 FEMA 3042 Substances 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 241001570521 Lonicera periclymenum Species 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- 241000179039 Paenibacillus Species 0.000 description 2
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 2
- 239000002262 Schiff base Substances 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- WAEFCMHZIBXWEH-UHFFFAOYSA-N [Cl].ClO Chemical compound [Cl].ClO WAEFCMHZIBXWEH-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 229960002233 benzalkonium bromide Drugs 0.000 description 2
- KHSLHYAUZSPBIU-UHFFFAOYSA-M benzododecinium bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 KHSLHYAUZSPBIU-UHFFFAOYSA-M 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 238000003421 catalytic decomposition reaction Methods 0.000 description 2
- 210000003850 cellular structure Anatomy 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- LRBQNJMCXXYXIU-QWKBTXIPSA-N gallotannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@H]2[C@@H]([C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-QWKBTXIPSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Natural products CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 229940087305 limonene Drugs 0.000 description 2
- 235000001510 limonene Nutrition 0.000 description 2
- 125000000396 limonene group Chemical group 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- VSUOKLTVXQRUSG-ZFORQUDYSA-N luteolin 7-O-beta-D-glucosiduronic acid Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 VSUOKLTVXQRUSG-ZFORQUDYSA-N 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical class C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000005065 mining Methods 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 239000005022 packaging material Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 125000003367 polycyclic group Chemical group 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 229950008882 polysorbate Drugs 0.000 description 2
- 229940068968 polysorbate 80 Drugs 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 230000008786 sensory perception of smell Effects 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- HUAUNKAZQWMVFY-UHFFFAOYSA-M sodium;oxocalcium;hydroxide Chemical compound [OH-].[Na+].[Ca]=O HUAUNKAZQWMVFY-UHFFFAOYSA-M 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 229940033123 tannic acid Drugs 0.000 description 2
- 235000015523 tannic acid Nutrition 0.000 description 2
- 229920002258 tannic acid Polymers 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 238000001931 thermography Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 125000005918 1,2-dimethylbutyl group Chemical group 0.000 description 1
- ISAOUZVKYLHALD-UHFFFAOYSA-N 1-chloro-1,3,5-triazinane-2,4,6-trione Chemical compound ClN1C(=O)NC(=O)NC1=O ISAOUZVKYLHALD-UHFFFAOYSA-N 0.000 description 1
- 125000006218 1-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- QAQJMLQRFWZOBN-UHFFFAOYSA-N 2-(3,4-dihydroxy-5-oxo-2,5-dihydrofuran-2-yl)-2-hydroxyethyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)C1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-UHFFFAOYSA-N 0.000 description 1
- KLZMUJRJFXYDCW-UHFFFAOYSA-N 2-[6-(diaminomethylideneamino)hexyl]guanidine;hydrochloride Chemical compound Cl.NC(N)=NCCCCCCN=C(N)N KLZMUJRJFXYDCW-UHFFFAOYSA-N 0.000 description 1
- WXHLLJAMBQLULT-UHFFFAOYSA-N 2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-n-(2-methyl-6-sulfanylphenyl)-1,3-thiazole-5-carboxamide;hydrate Chemical compound O.C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1S WXHLLJAMBQLULT-UHFFFAOYSA-N 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- 150000005351 2-phenylphenols Chemical class 0.000 description 1
- 125000003542 3-methylbutan-2-yl group Chemical group [H]C([H])([H])C([H])(*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- 206010000383 Accidental poisoning Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 238000006418 Brown reaction Methods 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- YCSMVPSDJIOXGN-UHFFFAOYSA-N CCCCCCCCCCCC[Na] Chemical compound CCCCCCCCCCCC[Na] YCSMVPSDJIOXGN-UHFFFAOYSA-N 0.000 description 1
- 208000025721 COVID-19 Diseases 0.000 description 1
- 241001678559 COVID-19 virus Species 0.000 description 1
- ZKQDCIXGCQPQNV-UHFFFAOYSA-N Calcium hypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-] ZKQDCIXGCQPQNV-UHFFFAOYSA-N 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 235000013175 Crataegus laevigata Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000009847 Cucumis melo var cantalupensis Nutrition 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 206010050429 Disinfectant poisoning Diseases 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- 241001411320 Eriogonum inflatum Species 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 206010017740 Gas poisoning Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 108010020056 Hydrogenase Proteins 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 244000167230 Lonicera japonica Species 0.000 description 1
- 235000017617 Lonicera japonica Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000581835 Monodora junodii Species 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 240000008801 Reseda odorata Species 0.000 description 1
- 235000002182 Reseda odorata Nutrition 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 125000000066 S-methyl group Chemical group [H]C([H])([H])S* 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical group [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 244000250129 Trigonella foenum graecum Species 0.000 description 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 235000005811 Viola adunca Nutrition 0.000 description 1
- 240000009038 Viola odorata Species 0.000 description 1
- 235000013487 Viola odorata Nutrition 0.000 description 1
- 235000002254 Viola papilionacea Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- JKBDUICXEYSXOI-UHFFFAOYSA-N [Na].SC(CO)CS Chemical compound [Na].SC(CO)CS JKBDUICXEYSXOI-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 229940021715 acetylcysteine injection Drugs 0.000 description 1
- 239000002696 acid base indicator Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000004887 air purification Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003616 anti-epidemic effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 210000004666 bacterial spore Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 1
- 229960000830 captopril Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229960002152 chlorhexidine acetate Drugs 0.000 description 1
- XTEGARKTQYYJKE-UHFFFAOYSA-N chloric acid Chemical compound OCl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-N 0.000 description 1
- 229940005991 chloric acid Drugs 0.000 description 1
- 229910001902 chlorine oxide Inorganic materials 0.000 description 1
- MAYPHUUCLRDEAZ-UHFFFAOYSA-N chlorine peroxide Chemical compound ClOOCl MAYPHUUCLRDEAZ-UHFFFAOYSA-N 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000006547 cyclononyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- UFULAYFCSOUIOV-UHFFFAOYSA-O cysteaminium Chemical compound [NH3+]CCS UFULAYFCSOUIOV-UHFFFAOYSA-O 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- OPGYRRGJRBEUFK-UHFFFAOYSA-L disodium;diacetate Chemical compound [Na+].[Na+].CC([O-])=O.CC([O-])=O OPGYRRGJRBEUFK-UHFFFAOYSA-L 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011152 fibreglass Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000019249 food preservative Nutrition 0.000 description 1
- 239000005452 food preservative Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229960000789 guanidine hydrochloride Drugs 0.000 description 1
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
- 244000237330 gutta percha tree Species 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 125000001841 imino group Chemical group [H]N=* 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- OCVXZQOKBHXGRU-UHFFFAOYSA-N iodine(1+) Chemical group [I+] OCVXZQOKBHXGRU-UHFFFAOYSA-N 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229960003151 mercaptamine Drugs 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229910052976 metal sulfide Inorganic materials 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 231100000017 mucous membrane irritation Toxicity 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 235000010298 natamycin Nutrition 0.000 description 1
- 239000004311 natamycin Substances 0.000 description 1
- NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 description 1
- 229960003255 natamycin Drugs 0.000 description 1
- 229910052754 neon Inorganic materials 0.000 description 1
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 208000007892 occupational asthma Diseases 0.000 description 1
- 235000010292 orthophenyl phenol Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 239000012476 oxidizable substance Substances 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- DHRLEVQXOMLTIM-UHFFFAOYSA-N phosphoric acid;trioxomolybdenum Chemical compound O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.OP(O)(O)=O DHRLEVQXOMLTIM-UHFFFAOYSA-N 0.000 description 1
- IYDGMDWEHDFVQI-UHFFFAOYSA-N phosphoric acid;trioxotungsten Chemical compound O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.OP(O)(O)=O IYDGMDWEHDFVQI-UHFFFAOYSA-N 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000056 polyoxyethylene ether Polymers 0.000 description 1
- 229940051841 polyoxyethylene ether Drugs 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 description 1
- 210000004777 protein coat Anatomy 0.000 description 1
- 201000003456 pulmonary hemosiderosis Diseases 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- WVTKBKWTSCPRNU-UHFFFAOYSA-N rac-Tetrandrin Natural products O1C(C(=CC=2CCN3C)OC)=CC=2C3CC(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2CC2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-UHFFFAOYSA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229940001607 sodium bisulfite Drugs 0.000 description 1
- 239000008354 sodium chloride injection Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000017454 sodium diacetate Nutrition 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 229940001474 sodium thiosulfate Drugs 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000002910 solid waste Substances 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940124547 specific antidotes Drugs 0.000 description 1
- 125000003003 spiro group Chemical group 0.000 description 1
- 210000004215 spore Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 125000002653 sulfanylmethyl group Chemical group [H]SC([H])([H])[*] 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229930006978 terpinene Natural products 0.000 description 1
- 150000003507 terpinene derivatives Chemical class 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000004861 thermometry Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000002341 toxic gas Substances 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 235000001019 trigonella foenum-graecum Nutrition 0.000 description 1
- 229960004418 trolamine Drugs 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
- A41D31/00—Materials specially adapted for outerwear
- A41D31/02—Layered materials
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
- A41D31/00—Materials specially adapted for outerwear
- A41D31/04—Materials specially adapted for outerwear characterised by special function or use
- A41D31/12—Hygroscopic; Water retaining
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
- A41D31/00—Materials specially adapted for outerwear
- A41D31/04—Materials specially adapted for outerwear characterised by special function or use
- A41D31/14—Air permeable, i.e. capable of being penetrated by gases
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D3/00—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances
- A62D3/02—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by biological methods, i.e. processes using enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D9/00—Composition of chemical substances for use in breathing apparatus
Definitions
- the present invention relates to the field of material technology, and in particular to a composition that adsorbs and neutralizes volatile gases of disinfectants, its use, and materials containing the same.
- High-efficiency disinfectants refer to disinfectants that can kill various microorganisms (including bacterial spores).
- Currently widely used disinfectants include chlorine-containing disinfectants (such as chloroisocyanuric acid disinfectant tablets, 84 disinfectant, bleaching powder, sodium hypochlorite, Chloric acid air disinfectant, liquid chlorine, and new chlorine dioxide, etc.), peroxide disinfectants (such as peracetic acid, hydrogen peroxide), aldehyde disinfectants, ethylene oxide, etc.
- chlorine-containing disinfectants and peroxide disinfectants are oxidizing disinfectants, also known as high redox potential disinfectants, which have broad-spectrum and efficient killing of microorganisms.
- this type of high-efficiency disinfectant is much more oxidative, corrosive, irritating, and allergenic to mucous membrane tissues such as skin, respiratory tract, and eyes than conventional medical skin and mucous membrane disinfectants such as iodine, benzalkonium bromide, and chlorhexidine.
- There have been reports of adverse reactions and physical damage to epidemic prevention personnel after being exposed to chlorine-containing disinfectants reports of occupational asthma caused by peracetic acid, and reports of people accidentally taking peracetic acid disinfectant and chlorine dioxide disinfectant tablets. Reports of poisonings. Therefore, the occupational exposure injuries of high-efficiency disinfectants and the rescue of accidental poisoning are issues involving the safety of global anti-epidemic chemicals.
- CN 2109208U discloses an anti-virus and anti-bacteria activated carbon fiber with strong adsorption force, which enables it to have efficient adsorption capacity and anti-toxic effect on harmful gases such as benzene, sulfur dioxide, chlorine, ammonia and bacteria, as well as bacteria.
- activated carbon usually needs to be in contact with tap water for more than 2 minutes to fully adsorb residual chlorine in tap water.
- the time it takes for volatile chlorine to pass through the mask is only a few milliseconds.
- the thin activated carbon fiber layer does not have time to capture inorganic small molecule gases such as chlorine. Only professional canisters or cartridges can filter them out. Therefore, activated carbon masks are mainly used to adsorb organic vapor and particulate matter with larger molecular volumes.
- CN 111394728A discloses a further treatment method for chlorine gas in an acid etching copper recovery system.
- the chlorine gas and the etching liquid are mixed with gas and liquid, and then sent into the first-stage iron absorption tank to react with metallic iron to produce ferric chloride.
- this technology is not suitable for use on masks because reduced iron powder is likely to be inhaled into the lungs, causing diseases similar to pulmonary hemosiderosis.
- CN 111330419A discloses a method for jointly absorbing chlorine gas using water and sodium hydroxide (liquid alkali).
- this technology is not suitable for use on masks. Alkaline substances may cause serious damage to facial skin and respiratory tract.
- the "Technical Specifications for Disinfectants” discloses a technical solution for using sodium thiosulfate to neutralize chlorine-containing disinfectants and peroxide disinfectants.
- Sodium thiosulfate is a weakly alkaline and strongly reducing substance that is basically not absorbed when taken orally and can neutralize the acidity and oxidation of oxidizing disinfectants.
- the irritation of this substance to the respiratory mucosa is unknown, and there is no safety study on airway inhalation of this strongly reducing inorganic substance.
- sodium thiosulfate may produce elemental sulfur particles under the action of weak oxidants, such as Cl 2 +Na 2 S 2 O 3 +H 2 O ⁇ 2NaCl+S ⁇ +H 2 SO 4 .
- This kind of new elemental sulfur particles are tiny and are inhalable particles. They may have adverse effects on lung tissue, so they are not suitable for use in masks involving respiratory protection.
- the "Expert Consensus on Health Emergency Rescue and Clinical Treatment at the Site of Sudden Mass Chlorine Gas Leak Accident (2017)" further pointed out that there is currently no specific antidote for chlorine gas poisoning.
- the present invention relates to a composition characterized by comprising, based on the total weight of the composition,: (A) about 0.1-99% by weight of biosorbent and (B) about 0.0001-99% % by weight of moisture attractant.
- the biosorbent is selected from one or more of the following: (a) compounds containing enol structures; (b) compounds containing sulfhydryl groups; (c) amino acids; (d) biological enzymes.
- the moisture-absorbing agent is selected from the group consisting of diethylene glycol, polyethylene glycol, propylene glycol, dipropylene glycol, glycerin, glycerol polyether, xylitol, sorbitol, propylene glycol glucoside, and sodium lactate. and combinations thereof.
- the composition further includes at least one of the following ingredients, based on the total weight of the composition: (e) about 0.00000001-1% by weight of a preservative; (f) about 0.00001-90% by weight of a preservative Acid-base buffer; (g) about 0.000001-5 wt% antioxidant; (h) about 0-1 wt% emulsifier; (i) about 0-20 wt% liquid sealant; (j) about 0 - 20% by weight of protein coagulant; (k) about 0-20% by weight of plant extract; (l) about 0.0001-2% by weight of odor masking agent.
- the invention relates to an aqueous solution, characterized in that it contains the composition of the invention.
- the composition is present in an amount of about 30-80% by weight, based on the total weight of the aqueous solution.
- the invention in another aspect, relates to a substrate, characterized in that the substrate contains the composition of the invention, and the substrate is selected from the group consisting of non-woven cloth, metal mesh, glass fiber, cotton cloth, and linen cloth. and filter cotton, preferably non-woven fabric.
- the present invention relates to a multi-layer material A, characterized in that the multi-layer material includes the base material of the present invention as a base material; and an activated carbon layer as the first filter layer.
- a second filter layer is further included between the base material and the first filter layer.
- the present invention relates to a multi-layer material B, characterized in that the multi-layer material includes the base material of the present invention as a first base material; an intermediate isolation layer including a porous breathable material that is not wetted by water. ;
- the second base material includes biological enzymes, moisture absorbing agents, preservatives and acid-base buffers.
- the invention relates to a mask, characterized in that the mask contains the base material or multi-layer material of the invention.
- the present invention relates to a method for preparing a mask of the present invention, which includes: (1) providing a composition solution of the present invention; (2) spraying the composition liquid of step (1) onto The inside and/or outside of the mask.
- Figure 1 shows the structural diagram of the mask A of the present invention
- Figure 2 shows the structural diagram of the mask B of the present invention
- Figure 3 shows the structural diagram of the mask C of the present invention
- Figure 4 shows the structural diagram of the mask D of the present invention
- Figure 5 shows the thermal imaging thermometer when wearing a disposable medical non-woven nursing mask or removing the above mask
- Figure 6 shows the thermal image temperature measurement chart when wearing cotton or removing the above mask
- Figure 7 shows the thermal image thermometry when wearing the mask A of the present invention or taking off the above mask
- Figure 8 shows a spray bottle storing a solution of the composition of the present invention
- Figure 9 shows a schematic diagram of using a spray bottle to prepare the mask of the present invention.
- 101 represents the base material
- 102 represents the ear hanging rope
- 201 represents the activated carbon layer
- 302 represents the middle isolation layer
- 301 represents the second base material
- 401 represents the base material
- 1001 represents a transparent plastic bottle
- 1002 Indicates the spray bottle button
- 1003 indicates the nozzle
- 1004 indicates the pipette
- 1005 indicates the liquid sealant
- 1006 indicates the composition solution.
- selected from refers to one or more elements from the group listed thereafter, selected independently, and may include combinations of two or more elements.
- one or more or “at least one” as used herein means one, two, three, four, five, six, seven, eight, nine or more.
- the terms “optionally” or “optionally” mean that the subsequently described event or circumstance may or may not occur, and that the description includes both the occurrence and absence of the stated event or circumstance.
- alkyl refers to a straight or branched saturated aliphatic hydrocarbon group consisting of carbon atoms and hydrogen atoms connected to the rest of the molecule by a single bond.
- Alkyl may have 1-10 carbon atoms, that is, "C 1 -C 10 alkyl", such as C 1 -C 4 alkyl, C 1 -C 3 alkyl, C 1 -C 2 alkyl, C 3 alkyl, C 4 alkyl, C 3 -C 6 alkyl.
- alkyl groups include, but are not limited to, methyl, ethyl, propyl, butyl, pentyl, hexyl, isopropyl, isobutyl, sec-butyl, tert-butyl, isopentyl, 2- Methylbutyl, 1-methylbutyl, 1-ethylpropyl, 1,2-dimethylpropyl, neopentyl, 1,1-dimethylpropyl, 4-methylpentyl, 3-methylpentyl, 2-methylpentyl, 1-methylpentyl, 2-ethylbutyl, 1-ethylbutyl, 3,3-dimethylbutyl, 2,2-di Methylbutyl, 1,1-dimethylbutyl, 2,3-dimethylbutyl, 1,3-dimethylbutyl or 1,2-dimethylbutyl, or their isomers body.
- cycloalkyl when used herein alone or in combination with other groups, refers to a saturated, non-aromatic monocyclic or polycyclic (such as bicyclic) hydrocarbon ring (e.g., monocyclic, such as cyclopropyl, cyclobutyl , cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl; or bicyclic, including spiro, fused or bridged systems (such as bicyclo[1.1.1]pentyl, bicyclo[2.2.1] Heptyl, bicyclo[3.2.1]octyl or bicyclo[5.2.0]nonyl, decahydronaphthyl, etc.).
- C 3-10 cycloalkyl refers to having 3-10 ring carbon atoms (such as 3, 4, 5, 6, 7, 8, 9 or 10) cycloalkyl groups.
- 3-18 membered ring when used herein alone or in combination with other groups, refers to a ring containing 3-12 atoms. Such rings may be saturated or unsaturated (ie, contain one or more double or triple bonds).
- “3-12-membered ring” can cover, for example, 3-6-membered, 6-9, 9-12, 12-15-membered and 15-18-membered rings, such as 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 or 18 membered rings.
- 0, 1 or 2 additional heteroatoms may optionally be included in the carbocyclic ring. Examples of heteroatoms are oxygen, sulfur, and nitrogen.
- 3-18 members in “3-18 membered ring” only refer to the number of carbon atoms therein. When additional heteroatoms are included, the number of heteroatoms is not counted in the number of ring atoms. For example, when it contains 1 heteroatom, a "3-18-membered ring" contains 4-19 ring atoms, of which 1 ring atom is a heteroatom and the rest are carbon atoms.
- halo or "halogen” or “halo” is understood to mean a fluorine (F), chlorine (Cl), bromine (Br) or iodine (I) atom, preferably a fluorine, chlorine, bromine atom.
- aryl refers to an all-carbon monocyclic or fused polycyclic (eg, bicyclic) aromatic ring group having a conjugated ⁇ electron system.
- an aryl group may have 6-14 carbon atoms, suitably 6-10, more suitably 6 or 10.
- Examples of aryl groups include, but are not limited to, phenyl, naphthyl, anthracenyl, and the like.
- amino acid refers to an organic compound or moiety consisting of amino and carboxyl functional groups and attached side chains, such as amino acids and their stereoisomers with the following chemical formula: H 2 N-(CR a R b ) t CO 2 H; wherein, R a and R b are each independently hydrogen or any substituent, and t is an integer greater than or equal to 1, such as 1, 2, 3, 4 or 5. Substituents may be linear or branched structures.
- R a and/or R b each independently correspond to, but are not limited to, hydrogen or side chains on naturally occurring amino acids, such as methyl, benzyl, hydroxymethyl, thiomethyl, carboxyl, carboxymethyl, Guanidinopropyl, etc.
- Amino acids include naturally occurring amino acids, unnatural amino acids, imino acids such as proline, amino acid analogs, and amino acid mimetics that function in a manner similar to naturally occurring amino acids, and also include their D and L stereoisomers form.
- Naturally encoded amino acids are protein amino acids known to those skilled in the art, including 20 common amino acids, namely alanine (Ala), arginine (Arg), asparagine (Asn), aspartic acid (Asp) ), cysteine (Cys), glutamine (Gln), glutamic acid (Glu), glycine (Gly), histidine (His), isoleucine (Ile), leucine (Leu) , Lysine (Lys), methionine (Met), phenylalanine (Phe), proline (Pro), serine (Ser), threonine (Thr), tryptophan (Trp), Tyrosine (Tyr) and valine (Val).
- moisture attractant refers to an agent used to absorb moisture.
- exemplary moisture attractants include, but are not limited to, diethylene glycol, polyethylene glycol, propylene glycol, dipropylene glycol, glycerin, glycerol polyethers, xylitol, sorbitol, propylene glycol glucoside, and sodium lactate.
- acid-base buffer refers to a solution used to control the pH of a solution to keep the pH within a certain range.
- exemplary acid-base buffers include, but are not limited to, citrate buffer, ammonium buffer, acetate buffer, phosphate buffer, and bicarbonate buffer.
- porous breathable material refers to a material that contains internal porosity with interconnected pores to allow airflow through the material.
- exemplary porous breathable materials include, but are not limited to, polyester filter wool, glass wool, rock wool, air filter cotton, and foam sponge.
- oxidizing disinfectant refers to a disinfectant containing oxidizing active substances, wherein exemplary oxidizing active substances include but are not limited to chlorine, hydrogen peroxide, aldehydes, peracetic acid, etc.
- the term "irritant gas” used herein refers to gases that are irritating to the eyes and respiratory mucosa, and are usually toxic gases commonly encountered in the chemical industry.
- the irritating gas refers to the gas contained in the oxidative disinfectant, which includes but is not limited to chlorine, chlorine dioxide, hydrogen peroxide, aldehydes, peracetic acid, etc.
- multilayer material A and multilayer material B used herein are only used to distinguish the above two multilayer materials containing different structures, but not in terms of nature, use or order.
- first base layer material “second base layer material”, “first filter layer” and “second filter layer” used herein are only used to distinguish them from other layers in the multi-layer material, and do not indicate the nature or use of the materials. or order, etc.
- the present invention relates to a composition for adsorbing and neutralizing irritating gases in an oxidative disinfectant, the composition comprising: (A) about 0.1-99 based on the total weight of the composition % by weight of biosorbent and (B) about 0.0001 to 99% by weight of moisture attractant.
- the composition includes: (A) about 26-46 wt% biosorbent and (B) about 44-64 wt% moisture attractant, based on the total weight of the composition. In a preferred embodiment, the composition contains: (A) about 36 wt% biosorbent and (B) about 54 wt% moisture attractant, based on the total weight of the composition.
- a biosorbent is a biological material capable of adsorbing and neutralizing irritating gases.
- exemplary biosorbents include, but are not limited to, small molecule compounds, high molecular polymers, amino acids, proteins, enzymes, etc.
- neutralizing irritating gases means that the biosorbent chemically reacts with the irritating gas to form environmentally friendly substances, or the biosorbent decomposes the irritating gas into environmentally friendly substances.
- the biosorbent is selected from one or more of the following:
- the enol structure refers to a chemical moiety with an alkene, which has a hydroxyl group attached to one end of the alkene double bond, and can be represented by the following chemical formula.
- the substituents R 1 and R 2 are the same or different substituents, or they are connected to form a cyclic compound with an enol structure.
- exemplary enol structure-containing compounds include, but are not limited to, vitamin C, vitamin B6, vitamin B9, catechol, vinyl alcohol, acetol, stigmastenol, tocotrienol, euphorbienol, isoenol, Ascorbic acid, ascorbyl palmitate, ascorbic acid glucoside, etc.
- the compound containing an enol structure has reducing properties and can adsorb oxidative and irritating gases in the air and undergo redox reactions with them to form environmentally friendly products. It can remove oxidative and irritating gases in the environment without affecting the environment and human health.
- some enol-containing compounds eg, vitamin C
- vitamin C will change color, for example, yellow, after being oxidized. Therefore, compounds containing an enol structure can act as indicators. For example, when a compound containing an enol structure turns yellow, it can be known that the content of the active ingredient (the unoxidized compound containing an enol structure) is low. It helps to remind people to timely update the compounds containing enol structure used.
- the compound containing an enol structure is a 3-18 membered cyclic enol compound containing 0, 1 or 2 additional heteroatoms independently selected from oxygen, sulfur, nitrogen and phosphorus and derivatives thereof substance, the ring may be optionally substituted by one or more substituents selected from the following, C 1-10 alkyl, C 3-10 cycloalkyl, aryl, aryl-C 1-4 alkyl, Wherein each alkyl, cycloalkyl, aryl group is unsubstituted or is independently selected from at least one group consisting of hydroxyl, CN, amino, acyl, carboxyl, halogen, C 1-10 alkyl, C 3-10 cycloalkyl , C 1-10 alkoxy substituent substituted.
- the compound containing an enol structure is a 3-18 membered cyclic enol compound containing 0, 1 or 2 additional heteroatoms independently selected from oxygen, sulfur and nitrogen, and derivatives thereof substance, the ring may be optionally substituted by one or more substituents selected from the following, C 1-10 alkyl, aryl, wherein each alkyl, aryl is unsubstituted or is independently substituted by at least one Substituted with a substituent selected from hydroxyl, amino, acyl, carboxyl, halogen, C 1-10 alkyl; vinyl alcohol; acetol.
- the compound containing an enol structure is selected from one or more of the following: vitamin C, vitamin B6, vitamin B9, catechol, vinyl alcohol, acetol, stigmasterene Alcohol, tocotrienol, euphorbienol, isoascorbic acid, ascorbyl palmitate, ascorbyl glucoside and its derivatives.
- the compound containing an enol structure is selected from one or more of the following: vitamin C, vitamin B6, and vitamin B9.
- the compound containing an enol structure is vitamin C.
- the content of the enol structure-containing compound is about 0.01-95% by weight based on the total weight of the composition. In a preferred embodiment, the content of the enol structure-containing compound is about 1 to 50% by weight based on the total weight of the composition. In a more preferred embodiment, the content of the enol structure-containing compound is about 13.2-14.8% by weight based on the total weight of the composition. For example, about 13.2% by weight, about 13.3% by weight, about 13.4% by weight, about 13.5% by weight, about 13.6% by weight, about 13.7% by weight, about 13.8% by weight, about 14% by weight, about 14.2% by weight, about 14.4% by weight. , about 14.6% by weight, about 14.8% by weight.
- the composition will produce a large amount of ketones and organic acid compounds after the redox reaction, which will increase the pH value of the composition system and make it easy to precipitate and crystallize at low temperatures. If the content of compounds containing an enol structure is too low, the oxidative irritating gases cannot be completely neutralized, and the discoloration of the mask is not obvious and it cannot function as an indicator.
- Thiol refers to the -SH group.
- the sulfhydryl group is reducing, so compounds containing sulfhydryl groups can be oxidized. Therefore, thiol-containing compounds can be used to adsorb oxidative and irritating gases in the air and undergo redox reactions with them to form environmentally friendly products. It can remove oxidative and irritating gases in the environment without affecting the polluted environment and human health.
- mercapto compounds have a strong affinity for heavy metal ions (such as Cu 2+ , Pb 2+ , Ag +, etc.) (its affinity is much higher than that of ethylenediaminetetraacetic acid EDTA), allowing it to combine with the above heavy metal ions to form Metal sulfides precipitate, thereby removing heavy metal ions from the environment.
- heavy metal ions such as Cu 2+ , Pb 2+ , Ag +, etc.
- EDTA ethylenediaminetetraacetic acid
- the thiol-containing compound is selected from the group consisting of cysteine, thioglycolic acid, dimercaprol, sodium dimercaprol, tiopronin, disodium dimercaptosulfate, cysteamine, penicillamine , lipoic acid, captopril, glutathione, alpha-lipoic acid, dithiothreitol and combinations thereof.
- the thiol-containing compound is selected from the group consisting of N-acyl-cysteine, N-alkyl-cysteine, dimercaprol, disodium dimercapto, and dithiothreose Alcohols and their combinations.
- the thiol-containing compound is selected from the group consisting of N-acetyl-L-cysteine, N-methyl-L-cysteine, N-ethyl-L-cysteine Acid, dimercaprol, disodium dimercapto, dithiothreitol and combinations thereof.
- the thiol-containing compound is N-acetyl-L-cysteine.
- the thiol-containing compound is present in an amount of about 0.0001 to 99% by weight, based on the total weight of the composition. In a preferred embodiment, the thiol-containing compound is present in an amount of about 0.1 to 20% by weight, based on the total weight of the composition. In a more preferred embodiment, the thiol-containing compound is present in an amount of about 3.0 to 3.4% by weight, based on the total weight of the composition. For example, about 3.0% by weight, about 3.02% by weight, about 3.06% by weight, about 3.1% by weight, about 3.12% by weight, about 3.16% by weight, about 3.20% by weight, about 3.23% by weight, about 3.26% by weight, about 3.28% by weight. , about 3.3% by weight, about 3.32% by weight, about 3.34% by weight, about 3.38% by weight, about 3.4% by weight. For example, about 1% by weight, about 1.125% by weight, and about 2.28% by weight.
- sulfhydryl-containing compounds themselves have a special odor, such as a garlic-like sulfide odor, too high a content of sulfhydryl-containing compounds can easily irritate the eyes and respiratory mucosa and should not be used in production practice, such as in daily necessities.
- An excessively low content of thiol-containing compounds makes the composition of the present invention insufficiently reducible, unable to adsorb and neutralize sufficient oxidative irritating gases, unable to reduce the activity of proteins, and is also unfavorable to the stability of compounds containing enol structures. .
- the primary amino groups in amino acids can react with aldehydes to obtain Schiff base compounds. Therefore, adding amino acids to the composition of the present invention can effectively adsorb and neutralize aldehyde-based compounds in the air, thereby reducing the damage caused by aldehyde compounds to the human body.
- the amino acid is selected from the group consisting of alanine, valine, leucine, isoleucine, methionine, proline, tryptophan, serine, tyrosine, cysteine Acid, phenylalanine, asparagine, glutamine, threonine, aspartic acid, glutamic acid, lysine, arginine, histidine, glycine and combinations thereof.
- the amino acid is selected from the group consisting of glycine, glutamic acid and combinations thereof.
- the amino acid is glycine.
- the amino acid is present in an amount of about 0.0001-95% by weight, based on the total weight of the composition. In a preferred embodiment, the amino acid is present in an amount of about 0.0001 to 85% by weight, based on the total weight of the composition. In a more preferred embodiment, the amino acid is present in an amount of about 20-25% by weight, based on the total weight of the composition.
- Bio enzymes refer to catalytic organic substances produced by living cells, which can specifically catalyze the transformation of substances. Different types of biological enzymes can be selected and used according to actual production or work purposes. For example, in order to absorb and break down hydrogen peroxide, catalase is used in the actual work process.
- the biological enzyme is selected from the group consisting of catalase and horseradish peroxidase.
- the biological enzyme is catalase.
- An exemplary catalase may be food-grade catalase with a specification of 50,000 U/g.
- the biological enzyme is present in an amount of about 0.0000001-20% by weight based on the total weight of the composition. In a preferred embodiment, the biological enzyme is present in an amount of about 0.02-0.2% by weight based on the total weight of the composition.
- Too high or too low biological enzyme content will reduce the speed of hydrogen peroxide catalytic decomposition.
- Hygroscopic agents are agents used to absorb moisture.
- Exemplary moisture attractants include, but are not limited to, diethylene glycol, polyethylene glycol, propylene glycol, dipropylene glycol, glycerin, glycerol polyether, xylitol, sorbitol, propylene glycol glucoside, sodium lactate, and the like.
- the hygroscopic agent in the composition of the present invention can absorb moisture in the air or additional added moisture, so that the composition becomes a moist or solution state, thereby dissolving the biosorbent in the moisture, thereby increasing the biosorbent
- the contact area with the adsorbed gas (such as chlorine, hydrogen peroxide, peracetic acid, aldehyde compounds, etc.) improves the efficiency of gas adsorption.
- the moisture attracting agent is selected from the group consisting of diethylene glycol, polyethylene glycol, propylene glycol, dipropylene glycol, glycerin, glycerol polyether, xylitol, sorbitol, propylene glycol glucoside, and sodium lactate. and combinations thereof.
- the moisture attractant is selected from the group consisting of glycerin, propylene glycol and combinations thereof.
- the moisture attracting agent is glycerol.
- the moisture attractant is present in an amount of about 0.0001-99% by weight. In a preferred embodiment, the moisture attractant is present in an amount of about 44 to 64% by weight. In a more preferred embodiment, the content of the moisture attractant is about 50-54% by weight, such as about 51% by weight, about 51.3% by weight, about 51.8% by weight, about 52% by weight, about 52.2% by weight, about 52.6% by weight. % by weight, about 53% by weight, about 53.5% by weight, about 53.8% by weight, about 54% by weight.
- Excessively high moisture attractant content will cause the composition to absorb a large amount of water, causing a sudden increase in liquid volume, reducing the breathability of the composition, thereby increasing the breathability resistance of the composition.
- a moisture absorbing agent when used in a protective mask, an excessively high moisture absorbing agent content will lead to a reduction in the breathability of the composition, thereby reducing the comfort of the protective mask.
- an excessively high moisture-drawing agent content will increase the viscosity of the composition, making it difficult to atomize and spray the composition solution. Too low a moisture attractant content cannot form a sufficient aquifer to effectively absorb water-soluble irritating gases.
- composition of the present invention also contains other components according to the needs of the actual situation and the optimal working environment required by the biosorbent.
- the compositions of the present invention may include a preservative.
- the composition of the present invention in order to make the biosorbent (such as amino acid) more susceptible to adsorbing aldehyde-based compounds, can include an acid-base buffer, wherein the acid-base buffer can adjust the working environment of the composition to be alkaline or alkaline. acidic.
- the composition further includes at least one of the following ingredients, based on the total weight of the composition:
- Preservatives refer to components that increase the stability of the compositions of the present invention.
- the preservative is selected from the group consisting of parahydroxybenzoic acid preservatives (parabens), benzoic acid preservatives, sorbic acid preservatives, benzalkonium bromide, chlorhexidine acetate, ortho Phenylphenols, hexamethyleneguanidine hydrochloride preservative, dehydroacetic acid, sodium diacetate, polylysine, sodium lactate, natamycin.
- the preservative is selected from paraben-based preservatives and sorbic acid-based preservatives.
- the preservative is a paraben catalyst.
- the preservative is ethylparaben (also known as ethylparaben).
- adding a preservative to the composition of the present invention can improve the stability of the composition and inhibit the growth of microorganisms.
- microorganisms that can inhibit growth include bacteria and fungi.
- the bacteria may be, for example, Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, hemolytic Streptococcus, etc.
- the preservative is present in an amount of about 0.00000001-1% by weight, based on the total weight of the composition. In a preferred embodiment, the preservative is present in an amount of about 0.001 to 0.5% by weight, based on the total weight of the composition. In a more preferred embodiment, the preservative is present in an amount of about 0.05 to 0.3% by weight, based on the total weight of the composition. For example, about 0.05% by weight, about 0.1% by weight, about 0.15% by weight, about 0.2% by weight, 0.25% by weight, and about 0.3% by weight.
- Acid-base buffer refers to a mixed solution composed of weak acid and its salts or weak base and its salts. It can offset and reduce the influence of external strong acid or strong base on the pH of the solution to a certain extent, thereby maintaining the pH value of the solution relatively Stablize.
- different acid-base buffers are selected to provide a suitable working environment for the biosorbent and other components, improve the adsorption of the biosorbent and neutralize stimulation. Efficiency of sexual gas.
- the acid-base buffer is selected from the group consisting of sodium bicarbonate buffer, phosphate buffer, sodium acetate, and sodium citrate buffer.
- the acid-base buffer is selected from phosphate buffer.
- the acid-base buffer is selected from sodium dihydrogen phosphate-disodium hydrogen phosphate buffer.
- the acid-base buffer is sodium bicarbonate buffer.
- the acid-base buffer used in the present invention can adjust the pH of the composition system to about 3-10. In a preferred embodiment, the acid-base buffer used in the present invention can adjust the pH of the composition system to about 5.0-6.2. In a more preferred embodiment, the acid-base buffer used in the present invention can adjust the pH of the composition system to about 5.8 (the average pH of the skin). A pH value that is too low is not conducive to the Schiff base reaction of amino acids and aldehyde compounds, and a pH value that is too high will cause the stability of compounds containing enol structures (such as vitamin C) to decrease.
- enol structures such as vitamin C
- the acid-base buffering agent is present in an amount of about 0.00001-90% by weight, based on the total weight of the composition. In a preferred embodiment, the acid-base buffering agent is present in an amount of about 0.01 to 5% by weight, based on the total weight of the composition. In a more preferred embodiment, the acid-base buffering agent is present in an amount of about 1.0-2.5% by weight, based on the total weight of the composition. For example, about 1.0% by weight, about 1.3% by weight, about 1.5% by weight, about 1.8% by weight, about 2.0% by weight, about 2.2% by weight, about 2.5% by weight.
- Antioxidants are substances that can delay, reduce, inhibit or prevent the oxidation of oxidizable substances.
- the biosorbent may be an enol structure-containing compound or a sulfhydryl group-containing compound with reducing properties. Therefore, in order to extend the storage time of the composition, antioxidants can be added to the composition to improve the durability of the composition.
- the antioxidant is selected from the group consisting of sodium metabisulfite, sodium bisulfite, sodium thiosulfate, vitamin E, L-ascorbyl palmitate, alkyl gallate, butylated hydroxyanisole, and butylated hydroxytoluene.
- the antioxidant is sodium metabisulfite.
- the antioxidant is present in an amount of about 0.000001-5% by weight, based on the total weight of the composition. In a preferred embodiment, the antioxidant is present in an amount of about 0.001 to 0.04% by weight, based on the total weight of the composition. In a more preferred embodiment, the acid-base buffering agent is present in an amount of about 0.01 to 0.03% by weight, based on the total weight of the composition. For example, about 0.01% by weight, about 0.013% by weight, about 0.015% by weight, about 0.017% by weight, about 0.02% by weight, about 0.023% by weight, about 0.025% by weight, about 0.027% by weight, about 0.029% by weight, about 0.03% by weight. .
- antioxidant content will exceed the upper limit of the amount of food additives, which is not conducive to the application of the composition of the present invention in daily necessities.
- Antioxidant content that is too low is insufficient to prevent enol compounds from being oxidized.
- Emulsifier refers to a class of compounds that can mix two or more mutually immiscible components to form a stable emulsion.
- an organic compound such as ethyl hydroxyphenyl ester
- its solubility in water is poor. Therefore, in order to improve the solubility of the preservative in water so that the composition of the present invention can have a longer shelf life, an emulsifier is added to the composition.
- the emulsifier is selected from polysorbate, triethanolamine, sorbitan oleate (Span), alkylphenol polyoxyethylene ether (OP), glyceryl stearate, lauryl Sodium sulfonate.
- the emulsifier is polysorbate.
- the emulsifier is polysorbate-80 (Tween-80).
- the emulsifier is present in an amount of from about 0 to 1% by weight, based on the total weight of the composition. In a preferred embodiment, the emulsifier is present in an amount of about 0.001 to 0.01% by weight, based on the total weight of the composition. For example, about 0.001% by weight, about 0.002% by weight, about 0.003% by weight, about 0.004% by weight, about 0.005% by weight, about 0.006% by weight, about 0.007% by weight, about 0.008% by weight, about 0.009% by weight, about 0.01% by weight. .
- Excessive emulsifier content will affect the preservative effect of the preservative. Too low emulsifier content is not conducive to the dissolution of preservatives. For example, when the composition of the present invention is stored under low temperature conditions, the preservative may precipitate from the composition system, so the preservative cannot effectively play a preservative role.
- the preservative used is a water-soluble preservative
- no emulsifier may be added to the composition.
- the composition of the present invention is easily in contact with air during storage and retrieval, forming an aqueous solution, and the compounds containing an enol structure and the compounds containing a thiol structure in the composition are easily oxidized by the air above the solution. Therefore, in order to reduce the losses caused by the above reasons to the composition and enhance the stability of the composition of the present invention, a liquid sealing agent is added to the solution of the composition to isolate the composition of the present invention from air.
- the liquid sealing agent is selected from edible oil, mineral oil, silicone oil, dimethicone and liquid paraffin (paraffin oil). In a preferred embodiment, the liquid sealing agent is liquid paraffin.
- the liquid sealant is present in an amount of about 0-20% by weight based on the total weight of the composition. In a preferred embodiment, the liquid sealant is present in an amount of about 1 to 10% by weight based on the total weight of the composition. For example, about 1% by weight, about 2% by weight, about 3% by weight, about 4% by weight, about 5% by weight, about 6% by weight, about 7% by weight, about 8% by weight, about 9% by weight, about 10% by weight. .
- liquid sealant The purpose of using a liquid sealant is to prevent the composition from being oxidized by air when it is taken out when the composition is stored in a rigid container (such as a stainless steel barrel). Excessively high liquid sealing agent content will cause low-polarity substances in the composition (such as fat-soluble preservatives) to dissolve in the liquid sealing agent, affecting the performance of the composition. Too low a liquid sealant content will prevent the liquid sealant from completely covering the surface of the composition. When packaging materials with air-isolating functions (such as vacuum bottles and ampoules with a piston AS plastic at the bottom) are used for retail packaging, liquid sealing agent does not need to be added.
- preservatives are only effective against microorganisms with cellular structures such as bacteria and fungi, but are not effective against microorganisms such as viruses that are composed of nucleic acid and protein shells. Therefore, adding a protein coagulant to the composition of the present invention can destroy the spatial conformation of the protein, prompting the protein shell of the virus to coagulate and lose biological activity, thereby possibly producing an antiviral effect.
- the protein coagulant is selected from sodium sulfate, ammonium sulfate, picric acid, phosphotungstic acid, phosphomolybdic acid, tannic acid, trichloroacetic acid, sulfosalicylic acid, urea, berberine, Tetrandrine, guanidine hydrochloride, gluconic acid and its salts, glucono-delta-lactone and combinations thereof.
- the protein coagulant is glucono-delta-lactone.
- the protein coagulant is present in an amount of about 0-20% by weight, based on the total weight of the composition. In a preferred embodiment, the protein coagulant is present in an amount of about 0.0001 to 20% by weight, based on the total weight of the composition. In a more preferred embodiment, the protein coagulant is present in an amount of about 0.1-0.3% by weight, such as about 0.1% by weight, about 0.13% by weight, about 0.15% by weight, about 0.18% by weight, about 0.18% by weight, based on the total weight of the composition. 0.2% by weight, about 0.25% by weight, about 0.3% by weight.
- Protein coagulant levels that are too low can reduce the bioactive ability of the antiviral protein coat of the composition.
- lower-content protein coagulants are less irritating and can be used for respiratory aerosol inhalation.
- compositions of the present invention may enhance the overall antimicrobial effectiveness of the compositions.
- the main component molecules of the plant extract contain at least 4 hydroxyl groups, which are selected from the group consisting of chlorogenic acid, luteolin, luteolin, and luteolin-7-O- ⁇ -D- Glucuronide and a plant extract of one of the proanthocyanidin components.
- the proanthocyanidin component can be selected from, for example, the leaves of Eucommia ulmoides, Lonicera japonica (honeysuckle), Lonicera erythricum, flowers of Honeysuckle or Lonicera tomentosa, Lonicera vine, and English hawthorn.
- the plant extract is grape seed extract (the main component of which is proanthocyanidins).
- the plant extract is present in an amount of about 0-20% by weight, based on the total weight of the composition. In a preferred embodiment, the plant extract is present in an amount of about 0.0001 to 20% by weight, based on the total weight of the composition. In a more preferred embodiment, the plant extract is present in an amount of about 0.5-0.9% by weight, based on the total weight of the composition. For example, about 0.5% by weight, about 0.6% by weight, about 0.7% by weight, about 0.8% by weight, and about 0.9% by weight.
- Plant extracts are usually brown, ultraviolet-blue-violet light-absorbing substances that can act as sunscreens. Too high a content of plant extracts will make the composition too dark, thus affecting its aesthetics. Too low a content of plant extracts will reduce the light absorption properties of the composition, which is not conducive to the stable storage of compounds containing enol structures that are sensitive to light, and will result in weakened antimicrobial activity. However, reducing the content of plant extracts can reduce irritation, making it suitable for respiratory aerosol inhalation.
- the odor masking agent may be a fruity flavor.
- the odor masking agent is selected from volatile oils from tangerine peels of the family Rutaceae, such as lemon oil, whose main component is limonene, and its minor components also include pinene, myrcene, terpinene, etc.
- lemon oil-containing botanicals such as tangerine peel, traditional Chinese medicine pieces
- eucalyptus lemon and pinole enteric-coated soft capsules (National Drug Approval No. H20052401) can improve the ciliary movement of tracheal mucosa, promote the secretion of respiratory glands, reduce phlegm, and promote self-purification of the respiratory tract.
- Pharmacological effects It is a classic auxiliary medicine for respiratory diseases.
- the odor masking agent is present in an amount of about 0.0001-2% by weight, based on the total weight of the composition. In a preferred embodiment, the odor masking agent is present in an amount of about 0.01 to 0.9% by weight, based on the total weight of the composition. In a more preferred embodiment, the odor masking agent is present in an amount of about 0.2 to 0.5% by weight, based on the total weight of the composition. For example, about 0.2% by weight, about 0.3% by weight, about 0.4% by weight, and about 0.5% by weight.
- composition of the present invention contains a relatively high concentration of compounds containing enol structures and compounds containing sulfhydryl groups, which can have a good protective effect on the above-mentioned polyphenols. Therefore, the combination of the composition of the present invention and the above-mentioned substances It also helps the above-mentioned substances to realize their commercial value.
- the isoelectric point of the S protein of 2019-nCoV is 6.24
- the isoelectric point of S1/S2/His is 4.41-5.87
- the isoelectric point of the key binding protein of hACE2/His is 5.19-6.11 through protein models. (average pH 5.60).
- the pH value of the composition of the present invention is set to 5.6-6.0 (preferably pH is 5.8). During use, the pH will gradually increase (when the composition is exposed to the air, the CO2 content will gradually decrease) , the pH of the composition will slowly rise to near the isoelectric point of the S protein, thereby precipitating the protein. Therefore, the composition of the present application may have the effect of inhibiting the activity of viral surface proteins.
- sulfhydryl structure in sulfhydryl-containing compounds can also act on the disulfide bonds of proteins, thereby destroying the protein conformation and reducing the viscosity of sputum.
- N-acetylcysteine aerosol inhalation has been regulated by European and Chinese drug regulators. Approved by the bureau for the treatment of phlegm (such as: acetylcysteine solution for inhalation, National Drug Approval H20150548, JX20020133, ZAMBON S.p.A.). Therefore, since the composition of the present invention contains a sulfhydryl compound, it can also achieve a long-lasting protein activity inhibition effect.
- the invention relates to an aqueous solution, characterized in that it contains the composition of the invention.
- the composition is present in an amount of about 30-80% by weight, based on the total weight of the aqueous solution. In a preferred embodiment, the composition is present in an amount of about 56-76% by weight, based on the total weight of the aqueous solution. In a more preferred embodiment, the composition is present in an amount of about 66% by weight, based on the total weight of the aqueous solution. For example, about 30% by weight, about 35% by weight, about 40% by weight, about 43% by weight, about 45% by weight, about 50% by weight, about 55% by weight, about 60% by weight, about 63% by weight, about 65% by weight. , about 66% by weight, about 67% by weight, about 70% by weight, about 76% by weight, about 75% by weight.
- an appropriate water content is conducive to the composition of the present invention achieving its technical effects, such as adsorbing and neutralizing irritating gases in oxidizing disinfectants, purifying the air, inhibiting biological protein activity, etc.
- Excessively high water content results in a low content of the composition, which is insufficient to achieve the technical effects of the present invention.
- Too low water content is not conducive to the full dissolution of the components, so that each component of the composition cannot be fully contacted with the adsorbed gas, so it cannot effectively adsorb and neutralize the irritating gases in the oxidizing disinfectant, and is not conducive to other Realization of technical effects.
- the composition aqueous solution of the present invention can absorb and neutralize irritating gases (such as irritating gases in oxidative disinfectants) more effectively, and the adsorption efficiency can be significantly improved.
- the invention relates to a substrate, characterized in that it contains a composition of the invention.
- the substrate is used to adsorb and neutralize irritating gases in oxidative disinfectants.
- composition of the invention is adsorbed onto the substrate.
- the base material of the present invention refers to a material product, such as sheet, metal plate, non-woven fabric, glass fiber, etc.
- a material product such as sheet, metal plate, non-woven fabric, glass fiber, etc.
- different materials can be attached to the surface of the substrate.
- activated carbon can be attached to the surface of the substrate.
- a weakly alkaline compound such as sodium bicarbonate
- reducing compounds such as compounds containing enol structures or compounds containing thiol groups, may be attached to the surface of the substrate.
- the substrate may be a metal mesh.
- the base material can be a non-woven fabric in a mask or a filter membrane in a gas mask.
- the substrate is selected from the group consisting of non-woven cloth, metal mesh, fiberglass, cotton cloth, linen cloth, and filter cotton.
- the substrate is non-woven fabric.
- the present invention relates to a multi-layer material A, characterized in that the multi-layer material A includes: the base material of the present invention as the base material; and the activated carbon layer as the first filter layer.
- the base material as the base material is selected from non-woven cloth, metal mesh, glass fiber, cotton cloth, linen cloth, and filter cotton.
- the substrate is non-woven fabric.
- the base material is attached with the composition of the present invention and can be used to adsorb and neutralize irritating gases.
- the irritating gases can be, for example, volatile gases in oxidizing disinfectants, such as chlorine in chlorine-containing disinfectants, The volatilized hydrogen peroxide in hydrogen peroxide disinfectants or the volatilized peracetic acid in peracetic acid-containing disinfectants.
- the irritating gas may be an aldehyde-based compound volatilized in a disinfectant containing an aldehyde-based compound.
- the multi-layer material A also includes an activated carbon layer as the first filter layer, where the activated carbon layer is used to adsorb peracetic acid, a volatile gas in the air, but does not have the effect of neutralizing peracetic acid.
- the multi-layer material A of the present invention further includes a second filter layer between the base material and the first filter layer.
- a second filter is also included between the base material of the multi-layer material A of the present invention and the first filter layer. layer.
- the substrate may be a metal mesh.
- the base material can be a non-woven fabric in a mask or a filter membrane in a gas mask.
- the second filter layer is selected from the group consisting of non-woven cloth, metal mesh, glass fiber, cotton cloth, linen cloth, and filter cotton.
- the second filter layer is non-woven fabric.
- the second filter layer is melt-blown non-woven fabric.
- the present invention relates to a multi-layer material B, characterized in that the multi-layer material B includes: the base material of the present invention as a first base material; an intermediate isolation layer; and a second base material.
- the first base material is the base material of the present invention, wherein the base material is as defined above.
- the middle isolation layer is composed of a porous breathable material that is not wetted by water, and is used to isolate the first base material and the second base material so that the two base materials can work in different environments.
- the first base layer material and the second base layer material have different working environments, for example, the pH of the two is different.
- the temperatures of the two are different.
- the humidity of the two is different.
- the middle isolation layer includes a porous breathable material that is not wetted by water.
- the porous breathable material is selected from the group consisting of polyester filter cotton, glass wool, rock wool, air filter cotton, and foam sponge.
- the porous breathable material is polyester filter cotton.
- the porous breathable material is an ethylene vinyl acetate (EVA) breathable sponge.
- the thickness of the intermediate isolation layer is about 0.1-15 mm. In a preferred embodiment, the thickness of the intermediate isolation layer is about 3 mm.
- the second base material includes biological enzymes, moisture absorbing agents, preservatives, and acid-base buffers, wherein the types of biological enzymes, moisture absorbing agents, acid-base buffers, and second base materials are as defined above.
- the biological enzyme is catalase.
- catalase is used to adsorb and decompose the volatile gas hydrogen peroxide.
- the biosorbent in the first base material and the catalase in the second base material need to work under different pH conditions, they can fully exert their respective adsorption and neutralization of irritating gases. Therefore, an intermediate isolation layer is provided between the first base material and the second base material, which can effectively isolate the components in the two materials.
- the middle isolation layer uses a porous breathable material that is not wetted by water. Gas can still pass through the middle isolation layer smoothly and be further adsorbed and neutralized by the active ingredients in the second base material.
- the present invention relates to a mask comprising the base material, multi-layer material A or multi-layer material B of the present invention, wherein the base material, multi-layer material A and multi-layer material B are as defined above.
- the present invention also relates to a method for preparing the mask of the present invention, which includes the following steps:
- step (3) Drying the base material obtained in step (2) under a protective gas atmosphere;
- the types and contents of the active ingredients or other ingredients in the first base layer material, the second base layer material, the second filter layer, the first filter layer, and the intermediate isolation layer are as defined above.
- the protective gas used in step (3) and step (5) is selected from nitrogen, helium, neon and carbon dioxide. In a preferred embodiment, the protective gas used in step (3) and step (5) is nitrogen.
- the protective gases used in step (3) and step (6) may be the same or different.
- the drying temperature in step (3) and step (6) is about 50-80°C or room temperature. In a preferred embodiment, the drying temperature in step (3) and step (6) is about 60°C.
- the present invention also relates to a method for quickly preparing the mask of the present invention, which includes the following steps:
- step (2) Spray the composition liquid of step (1) onto the inside and/or outside of the mask by spraying.
- composition solution of step (1) is stored in a spray bottle as described in Figure 8.
- step (2) the composition of step (1) is sprayed via a spray bottle as shown in FIG. 8, see FIG. 9 for the spraying process.
- the composition spraying position is about 5-10 cm above the mask.
- the volume of the composition solution sprayed in step (2) is about 3.2 mL.
- spray the inner and outer sides of the mask about 15-20 times to complete the spraying of the composition solution.
- the inner and outer sides of the mask are sprayed about 17-19 times to complete the spraying of the composition solution. For example, about 15 times, about 16 times, about 17 times, about 18 times, about 19 times, and about 20 times.
- composition of the present invention The stability of the composition of the present invention and its ability to adsorb and neutralize irritating gases in oxidizing disinfectant solutions
- composition of the present invention to adsorb and neutralize irritating gases in oxidizing disinfectant solutions
- composition of the present invention to neutralize irritating gases in the oxidizing disinfectant solution is tested by the following method A.
- the ability of the composition of the present invention to adsorb and neutralize irritating gases in oxidative disinfectants is determined by the method described above.
- the adsorption of chlorine gas in the disinfectant by the composition of the present invention is determined by titration of the aqueous solution of the composition of the present invention with trichloroisocyanuric acid disinfectant, sodium hypochlorite disinfectant and chlorine dioxide disinfectant aqueous solution. and ability.
- the ability of the composition of the present invention to adsorb and neutralize hydrogen peroxide in the disinfectant is determined by titration of an aqueous solution of the composition of the present invention with a hydrogen peroxide wash solution.
- the adsorption and neutralization ability of the composition of the present invention on the peracetic acid in the disinfectant is determined by titration of the aqueous solution of the composition of the present invention with an oxyacetic acid disinfectant solution.
- titration indicator when titrating chlorine-containing disinfectants, use chlorine test paper as a titration indicator.
- chlorine test paper For another example, when titrating hydrogen peroxide disinfectant, use hydrogen peroxide test paper as a titration indicator.
- hydrogen peroxide test paper For another example, when titrating peracetic acid disinfectant, use peracetic acid test paper as a titration indicator.
- a secondary indicator is used in determining the titration end point.
- chlorine test paper is used as an auxiliary indicator to help determine the titration endpoint of hydrogen peroxide and peracetic acid disinfectants.
- the ability of the composition of the present invention to neutralize irritating gases in the oxidative disinfectant solution is tested by the following method A1.
- composition aqueous solution of the present invention wherein the content of the active ingredient (enol structure-containing compound and/or thiol structure-containing compound and/or amino acid) in the composition aqueous solution is about 2-8% by weight;
- step (3) Use the disinfectant solution obtained in step (1) to titrate 1 mL of the composition aqueous solution in step (2), and record the volume of disinfectant solution consumed at the end point of the titration.
- the trichloroisocyanuric acid aqueous solution is prepared by the above method to perform a titration experiment. At the end point of the titration, the volume of the trichloroisocyanuric acid aqueous solution consumed by the titration is about 5-50 mL. In a preferred embodiment, the trichloroisocyanuric acid aqueous solution is prepared by the above method to perform a titration experiment. At the titration end point, the volume of the trichloroisocyanuric acid aqueous solution consumed by the titration is about 10-30 mL.
- the sodium hypochlorite disinfectant aqueous solution is prepared by the above method to perform a titration experiment. At the titration end point, the volume of the sodium hypochlorite disinfectant aqueous solution consumed by the titration is about 5-50 mL. In a preferred embodiment, the sodium hypochlorite disinfectant aqueous solution is prepared by the above method for a titration experiment. At the end point of the titration, the volume of the sodium hypochlorite disinfectant aqueous solution consumed by the titration is about 10-30 mL.
- a chlorine dioxide disinfectant aqueous solution is prepared by the above method to perform a titration experiment. At the end point of the titration, the volume of the chlorine dioxide disinfectant aqueous solution consumed by the titration is about 50-150 mL.
- the sodium hypochlorite disinfectant aqueous solution is prepared by the above method for a titration experiment. At the end point of the titration, the volume of the sodium hypochlorite disinfectant aqueous solution consumed by the titration is about 70-130 mL.
- the hydrogen peroxide wash solution is prepared by the above method to perform a titration experiment. At the end point of the titration, the volume of hydrogen peroxide wash solution consumed by the titration is about 0.08-1 mL. In a preferred embodiment, the hydrogen peroxide wash solution is prepared by the above method to perform a titration experiment. At the end point of the titration, the volume of hydrogen peroxide wash solution consumed by the titration is about 0.08-0.5 mL.
- the peracetic acid disinfectant solution is prepared by the above method for a titration experiment. At the end point of the titration, the volume of the peracetic acid disinfectant solution consumed by the titration is about 0.4-2.5 mL. In a preferred embodiment, the peracetic acid disinfectant solution is prepared by the above method for a titration experiment. At the end point of the titration, the volume of the peracetic acid disinfectant solution consumed by the titration is about 0.4-2.0 mL.
- the glutaraldehyde disinfectant solution is prepared by the above method to perform a titration experiment. At the end point of the titration, the volume of the glutaraldehyde disinfectant solution consumed by the titration is about 3-5 mL. In a preferred embodiment, the glutaraldehyde disinfectant solution is prepared through the above method for a titration experiment. At the end point of the titration, the volume of peracetic acid disinfectant solution consumed by the titration is about 3.5-4.5 mL.
- composition of the present invention is tested by the following method.
- step (3) Use the disinfectant aqueous solution of step (1) to titrate the composition aqueous solution of step (2), and record the volume C 0 of the disinfectant aqueous solution consumed at the end point of the titration;
- step (1) Store the aqueous composition solution of step (1) in a closed space at a constant temperature for a period of time;
- step (1) Use the disinfectant aqueous solution of step (1) to titrate the composition aqueous solution of step (4), and record the volume C of the disinfectant aqueous solution consumed at the end point of the titration;
- k represents the rate constant (d -1 )
- C 0 represents the initial concentration
- C represents the concentration at t
- t-time is days (d)
- t 1/2 represents the half-life.
- composition of the invention is tested by the following method:
- composition aqueous solution of the present invention wherein the content of the active ingredient (enol structure-containing compound and/or thiol structure-containing compound and/or amino acid) in the composition aqueous solution is about 2-3% by weight;
- step (3) Use the disinfectant solution obtained in step (1) to titrate 1 mL of the aqueous composition solution of step (2), and record the volume C 0 of the disinfectant solution consumed at the end point of the titration;
- step (2) Store the aqueous composition solution of step (2) in a room temperature space (such as an indoor room with a north-facing window, no direct sunlight, but with natural light and fluorescent indoor lighting) for about 60-365 days.
- a room temperature space such as an indoor room with a north-facing window, no direct sunlight, but with natural light and fluorescent indoor lighting
- step (1) Use the disinfectant solution obtained in step (1) to titrate 1 mL of the aqueous composition solution of step (4), and record the volume C of the disinfectant solution consumed at the end point of the titration;
- an aqueous solution of trichloroisocyanuric acid is prepared by the above method and subjected to a titration experiment. After calculation, the half-life of the composition of the present invention is approximately 360-3600 days. In a preferred embodiment, an aqueous solution of trichloroisocyanuric acid is prepared by the above method and subjected to a titration experiment. After calculation, the half-life of the composition of the present invention is approximately 361-3300 days. For example, 365 days, 443 days, 443 days, 682 days, 1000 days, 2000 days, 3000 days, 3253 days.
- compositions of the present invention are used to adsorb and neutralize irritating gases.
- WHO recommends disinfectants containing ethanol or isopropyl alcohol as the main ingredient (i.e., alcohol-based disinfectants) for skin disinfection.
- alcohol-based disinfectants i.e., ethanol or isopropyl alcohol as the main ingredient
- the present invention designs relevant tests to test the compatibility of the composition with alcohol-based disinfectants.
- the disinfection effect of the composition of the present invention and its compatibility with alcohol-based disinfectants were tested by the following method.
- step (3) Shake the container in step (3) for 5 minutes, and then observe the protein denaturation and precipitation effect.
- the pH of Composition 1 as well as Composition 2 is about 5.5-6.2.
- composition 2 or the combination of composition 2 and disinfecting alcohol when added in step (2), the effect of protein denaturation and precipitation can be observed.
- the ability of the mask of the present invention to neutralize irritating gases in the oxidative disinfectant solution is tested through the following two methods, namely qualitative testing and quantitative testing.
- step (3) Place the disinfectant aqueous solution of step (2) in a closed container, and shake the container to fill the container with volatile irritating gas;
- the disinfectant aqueous solution configured in step (2) of method B and step (3) of method C is selected from the group consisting of chlorine-containing disinfectant aqueous solution, hydrogen peroxide wash solution, peracetic acid disinfectant solution, and chlorine dioxide disinfection and glutaraldehyde disinfectant.
- the chlorine-containing disinfectant aqueous solution is selected from the group consisting of trichloroisonitrile uric acid disinfectant solution and sodium hypochlorite disinfectant solution.
- the concentration of the disinfectant aqueous solution configured in step (2) of method B and step (3) of method C is selected from the group consisting of 1000ppm, 30000ppm, 5000ppm, 100ppm and 20000ppm.
- the disinfectant aqueous solution configured in step (2) of method B and step (3) of method C includes 1000 ppm chlorine-containing disinfectant solution, 30000 ppm hydrogen peroxide wash solution, 5000 ppm peracetic acid disinfectant solution, 100ppm chlorine dioxide disinfectant and 20000ppm glutaraldehyde disinfectant.
- the closed container used in Method B is a 100 ml iodine flask.
- the amount of disinfectant used is about 5-10 mL.
- the amount of disinfectant used is about 5-10 mL.
- the test paper used in Method C is selected from the group consisting of chlorine test paper, chlorine dioxide test paper and glutaraldehyde test paper.
- the test paper used in method B is chlorine test paper
- the test paper used in method C is chlorine dioxide test paper
- glutaraldehyde disinfectant the test paper used in method C is glutaraldehyde test paper.
- the distance between the two pieces of detection test paper is 3-5 mm to facilitate the passage of airflow.
- the tester before wearing the mask of the present invention, can smell a strong irritating smell in the closed container; after wearing the mask of the present invention, the tester can smell the smell in about 2- No pungent odor can be smelled in the closed container within 5 minutes.
- the detection is only carried out by method C.
- test paper changes color on the outside of the mask of the present invention, but does not change color on the inside of the mask of the present invention.
- step (2) Dissolve the mask in step (1) in water to obtain a mask extract
- step (3) Use the disinfectant aqueous solution from step (3) to titrate the mask extract from step (2), and record the disinfectant aqueous solution consumed at the end point of the titration.
- the ability of the mask of the present invention to neutralize irritating gases in the oxidative disinfectant solution is quantitatively tested by the following method D1:
- step (2) Dissolve the mask in step (1) in 100 mL of water to obtain the mask extract;
- step (2) Take 10 mL of the mask extract from step (2), titrate the mask extract with the disinfectant aqueous solution from step (3), and record the disinfectant aqueous solution consumed at the end point of the titration;
- step (4) Amplify the titration result of step (4) 10 times to obtain the mask's ability to neutralize irritating gases in the oxidizing disinfectant solution.
- the titration indicator is selected as described in Method A.
- the mask of the present invention may contain liquid in an amount of about 3-4 mL.
- liquid in an amount of about 3-4 mL.
- the mask extract of the present invention is titrated by the above method. At the end point of the titration, the volume of the trichloroisocyanuric acid aqueous solution consumed is about 90-100 mL.
- the mask extract of the present invention is titrated by the above method, and at the end point of the titration, the volume of hydrogen peroxide wash solution consumed is about 1-2 mL.
- the mask extract of the present invention is titrated by the above method, and at the end point of the titration, the volume of peracetic acid disinfectant consumed is about 8-10 mL.
- the mask extract of the present invention is titrated by the above method.
- the volume of the consumed chlorine dioxide disinfectant aqueous solution is about 350-450 mL.
- the mask extract of the present invention is titrated by the above method, and at the end point of the titration, the volume of glutaraldehyde disinfectant solution consumed is about 10-15 mL.
- the stability of the mask of the present invention is tested through the following three methods, including qualitative testing, quantitative testing and microbial content determination.
- the stability of the mask of the present invention was qualitatively tested by the following methods E and F.
- step (1) Place the mask in step (1) in an environment with a relative humidity of 70-95% and a temperature of 25-35°C for 14 days;
- step (3) The tester wears the mask obtained in step (3) for 30 minutes;
- step (1) Place the mask in step (1) in an environment with a relative humidity of 70-95% and a temperature of 25-35°C for 14 days;
- step (3) The tester wears the mask obtained in step (3) for 30 minutes;
- the disinfectant solution, the concentration of the disinfectant solution, and the amount of the disinfectant solution used in Methods E and F are as described above.
- the tester before wearing the mask of the present invention, can smell a strong pungent odor in the closed container; after wearing the mask of the present invention, the tester can smell a weak smell The smell of disinfectant is non-irritating.
- test paper changes color on the outside of the mask of the present invention, but does not change color on the inside of the mask of the present invention.
- the stability of the mask of the present invention is tested by the following method G.
- step (1) Place the mask in step (1) in an environment with a relative humidity of 70-95% and a temperature of 25-35°C for 14 days;
- the titration indicator is selected as described in Method A.
- the mask extract of the present invention is titrated by the above method. At the end point of the titration, the volume of the trichloroisocyanuric acid aqueous solution consumed is about 30-40 mL.
- the mask extract of the present invention is titrated by the above method, and at the end point of the titration, the volume of hydrogen peroxide wash solution consumed is about 0.3-0.4 mL.
- the mask extract of the present invention is titrated by the above method. At the end point of the titration, the volume of peracetic acid disinfectant consumed is about 3-4 mL.
- the mask extract of the present invention is titrated by the above method.
- the volume of the consumed chlorine dioxide disinfectant aqueous solution is about 170-180 mL.
- the mask extract of the present invention is titrated by the above method. At the end point of the titration, the volume of glutaraldehyde disinfectant solution consumed is about 10-12 mL.
- the stability of the mask of the present invention is tested by the following method H.
- the detected flora species include bacteria, fungi, and the like.
- Exemplary bacteria can be, for example, coliforms, Pseudomonas aeruginosa, Staphylococcus aureus, hemolytic Streptococcus, etc.
- the mask extract of the present invention is detected by the above method. After 14 days, the number of coliform bacteria is 0.
- the mask extract of the present invention is detected by the above method. After 14 days, the number of Pseudomonas aeruginosa bacterial colonies is 0.
- the mask extract of the present invention is detected by the above method. After 14 days, the number of Staphylococcus aureus colonies is 0.
- the mask extract of the present invention is detected by the above method. After 14 days, the number of hemolytic streptococci is 0.
- the mask extract of the present invention is detected by the above method. After 14 days, the number of fungal colonies is 0.
- the mask extract of the present invention is tested by the above method. After 14 days, the total number of bacterial colonies is 250 CFU/g, wherein the bacteria are non-pathogenic Paenibacillus urinae.
- the color development ability of the mask of the present invention is tested by the following method I.
- the above-mentioned method I is used to simulate the scenario of the mask of the present invention after repeated use.
- the method of heating the mask in Method 1 is fumigation, and the fumigation temperature is about 40-94°C.
- the method of heating the mask in Method 1 is fumigation, and the fumigation time is about 2-6 hours. In a preferred embodiment, after heating and fumigation, it is continued to be placed in a residual heat environment for about 16-18 hours.
- the type and concentration of the disinfectant solution are as described in methods B and C above.
- the mask of the present invention will turn red after passing through the gas environment of high-concentration chlorine-containing disinfectant (such as hypochlorous acid disinfectant, chlorine dioxide disinfectant).
- high-concentration chlorine-containing disinfectant such as hypochlorous acid disinfectant, chlorine dioxide disinfectant.
- the mask of the present invention will turn into deep yellow after passing through the gas environment of high-concentration peroxide disinfectant.
- the mask of the present invention after passing through the gas environment of high-concentration glutaraldehyde disinfectant solution, the mask of the present invention will turn into dark brown.
- step (3) of method 1 before heating in step (3) of method 1, the following steps are also included:
- the detection test paper is selected as described in method C above.
- test paper on the inside of the mask of the present invention does not change color.
- test paper on the inside of the mask of the present invention slightly changes color.
- test paper on the inner side of the mask of the present invention after passing through the gas environment of high-concentration peracetic acid disinfectant solution, partially changes color.
- test paper on the inside of the mask of the present invention does not change color.
- test paper on the inside of the mask of the present invention does not change color.
- the heat dissipation ability of the mask of the present invention is tested by the following method J.
- the tester wears a mask and takes a thermal image temperature measurement
- the tester takes off the mask and takes a thermal image temperature measurement.
- the temperature of the area of the mask of the present invention that contacts the skin is about 2-3°C lower than the area below the nostrils that does not contact the skin. For example, about 2°C, about 2.2°C, about 2.4°C, about 2.6°C, about 2.8°C, and about 3°C.
- the composition of the present invention uses a biosorbent and a hygroscopic agent. Through the adsorption effect of the hygroscopic agent on water, the composition becomes a moist or solution state, thereby increasing the contact area between the active ingredient biosorbent and irritating gases. , effectively improve the efficiency of adsorbing and neutralizing irritating gases, and can effectively reduce the concentration of certain irritating gases in the air, such as chlorine, chlorine dioxide, hydrogen peroxide, peracetic acid and aldehyde compounds, etc. In addition, since the composition of the present invention can be changed into a moist or solution state, which increases the contact surface between the active ingredients and irritating gases, the composition of the present invention can absorb and neutralize it more effectively than vitamin C itself. Irritating gas.
- the aqueous composition solution of the present invention can also effectively absorb and neutralize irritating gases, especially irritating gases in oxidative disinfectants. Compared with the aqueous solution of vitamin C, the aqueous solution of the composition of the present invention can significantly improve the absorption capacity of irritating gases.
- the base material containing the composition of the present invention can also effectively absorb and neutralize the irritating odor gas generated by the volatilization of high-efficiency disinfectants in the air, and is suitable for disinfection workers such as hospital infection control and epidemic prevention.
- the base material containing the composition of the present invention can also effectively absorb and neutralize the irritating odor gas generated by the volatilization of high-efficiency disinfectants in the air, and is suitable for disinfection workers such as hospital infection control and epidemic prevention.
- it provides protective effects on the respiratory tract, skin, and mucous membranes; it can also be used as an antagonist for those who accidentally ingest or misuse high-efficiency disinfectants, leading to disinfectant poisoning.
- the base material containing the composition of the present invention can also be used in many technical fields such as daily cleaning disinfection products and air freshening equipment (such as reducing the concentration of formaldehyde and glutaraldehyde in the environment), and may be used for microbial protection in certain specific fields. or play a role in air purification.
- the multilayer material containing the composition of the present invention can adsorb and neutralize a variety of irritating gases, so it can be applied to different occasions and effectively adsorb and neutralize chlorine, hydrogen peroxide, peracetic acid, and aldehydes. Compounds and other gases.
- masks containing the composition of the present invention may reduce the use of activated carbon masks in some specific fields, and the components in the composition are mostly edible or harmless substances to the human body.
- masks containing the composition of the present invention may reduce the risk of activated carbon powder in traditional activated carbon masks being inhaled by the human body or polluting the working environment. This is because activated carbon requires high energy consumption in the production process, and old activated carbon that has adsorbed toxic and hazardous substances is considered hazardous solid waste by current regulations in some countries.
- the active ingredients in the base material, multi-layer material or mask containing the composition of the present invention can be extracted by solvent to obtain an extract of the above-mentioned materials. Therefore, in an emergency, it is also possible to quickly extract the active ingredients from the material of the present invention.
- the extract of the active ingredient biosorbent can be used for on-site detoxification of those who accidentally ingested or misused the disinfectant through oral administration, skin and mucous membrane rinses, wet compresses, etc.
- the multi-layer material containing the composition of the present invention can achieve a hygroscopic agent-water concentration gradient balance between the center and edge positions of the multi-layer material, which is conducive to the volatilization of moisture and taking it away. heat, thereby lowering the temperature around the multilayer material.
- the wearer's facial temperature will be lower and the wearer will not feel stuffy.
- the facial skin temperature is lower than the skin temperature under the nostrils.
- composition of the present invention has the property of color development and indication, and the composition will change color after high-intensity use in the air. Therefore, when the composition of the present invention is used in products such as masks and multi-layer materials, it can provide timely feedback on the status of active ingredients and facilitate replacement of the composition.
- the composition of the present invention has excellent stability.
- the composition of the present invention contains bioactive ingredients such as enol-containing compounds, sulfhydryl-containing compounds, and amino acids. Even if it is left standing in the air for a long time, the composition can still absorb and neutralize irritating gases in the air. , such as chlorine, chlorine dioxide, hydrogen peroxide, peracetic acid and aldehyde compounds, etc.
- adding plant extracts to the composition of the present invention can have a light-shielding effect and greatly increase the shelf life of the active ingredients, allowing them to absorb and neutralize irritating gases in the air after long-term storage.
- the composition of the present invention has better stability.
- compositions of the present invention do not affect the performance of disinfecting alcohols.
- the composition also contains protein coagulant and plant extract components.
- the corresponding composition may have the effect of inhibiting the activity of surface proteins of microorganisms such as viruses, bacteria, fungi, etc., and may enhance and prolong the activity of surface proteins of microorganisms such as viruses, bacteria, and fungi when used in conjunction with disinfectant alcohol.
- the disinfection effect of alcohol also reduces the irritation of disinfectant alcohol to the skin.
- Trichloroisocyanuric acid disinfectant tablets Hangzhou Langso Medical Disinfectant Co., Ltd. Available chlorine content is 500 ⁇ 50mg/tablet.
- Sodium hypochlorite disinfectant Hangzhou Langso Medical Disinfectant Co., Ltd. Concentration 4.5-5.5% by weight.
- Chlorine dioxide disinfectant tablets Beijing Hualong Xingyu Technology Development Co., Ltd. Chlorine dioxide content is 100 ⁇ 10mg/tablet.
- Hydrogen peroxide lotion Shandong Ruitaiqi Washing and Disinfection Technology Co., Ltd. Concentration 2.5-3.5% by weight.
- Peracetic acid disinfectant (binary packaging): Shandong Anjie Hi-Tech Disinfection Technology Co., Ltd. Concentration 15-18% by weight.
- Glutaraldehyde disinfectant Shanghai Likang Disinfection High-Tech Co., Ltd. Concentration 2.1-2.6% by weight.
- Chlorine test paper Hangzhou Langso Medical Disinfectant Co., Ltd. The concentration is 0-2000ppm.
- Hydrogen peroxide test paper Hangzhou Luheng Biotechnology Co., Ltd. The concentration is 0-25ppm.
- Peracetic acid test paper Hangzhou Luheng Biotechnology Co., Ltd. The concentration is 0-40ppm.
- Glutaraldehyde test paper Hangzhou Luheng Biotechnology Co., Ltd. The concentration is 0-3% by weight.
- Chlorine dioxide test paper Changsha Shangqing Environmental Protection Technology Co., Ltd. The concentration is 0-20ppm.
- Formaldehyde solution Sinopharm Chemical Reagent Co., Ltd. Analytically pure (contains methanol inhibitor). Content 37-40% by weight.
- NaHCO 3 sodium bicarbonate: Tianjin Zhiyuan Chemical Reagent Co., Ltd. Analytically pure.
- Vitamin C (ascorbic acid): purchased from Fuchen (Tianjin) Chemical Reagent Co., Ltd. Analytically pure.
- Acetylcysteine injection (4g: 20ml): for content analysis, Hangzhou Minsheng Pharmaceutical Co., Ltd., national drug approval number H20051788.
- N-acetylcysteine for preparation, Henan Jimei Chemical Products Co., Ltd., food additive.
- EDTA Na 2 (disodium ethylenediaminetetraacetate): Shanghai Chemical Reagent Co., Ltd. Analytically pure.
- Glycerin Hunan Erkang Pharmaceutical Co., Ltd. medical supplements.
- Propylene glycol (1,2 propylene glycol): Hunan Erkang Pharmaceutical Co., Ltd. medical supplements.
- Sodium hydrogen phosphate-disodium hydrogen phosphate buffer Nanjing Chemical Reagent Co., Ltd. Analytically pure, self-prepared.
- Ethylparaben Hunan Erkang Pharmaceutical Co., Ltd. medical supplements.
- Activated carbon layer fabric (carbon sandwiched non-woven fabric): Kunshan Green Chuang Electronic Technology Co., Ltd.
- Polyester filter cotton primary air filter cotton, thickness 0.3-1mm.
- Catalase Henan Yangshao Biochemical Engineering Co., Ltd. food ingredients.
- L-Alanine Henan Jiazhi Chemical Products Co., Ltd. Food grade additives.
- L-serine Henan Jiazhi Chemical Products Co., Ltd. Food grade additives.
- Polysorbate-80 Taicang Pharmaceutical Factory. medical supplements.
- Triethanolamine Sinopharm Chemical Reagent Co., Ltd. Analytically pure.
- Disinfection alcohol Prepare your own with absolute ethanol and water, or use commercially available finished products directly, with an ethanol content of 70-75% (V/V). Changshu Yangyuan Chemical Co., Ltd. Analytically pure.
- Egg white The egg white part of commercially available raw eggs is rich in a variety of proteins, with the main component being ovalbumin.
- Cotton masks The weight is about 9.8g/piece, double-layer pure cotton knitted fabric. It is a washable and reusable daily knitted mask mainly used for decoration, cleaning, and warmth.
- the estimated cotton thread specification is 40S, and the density of each layer of fabric is about 200g/ m2 . , filter layer area is about 105.2cm 2 , neutral packaging, selling price is about 0.63RMB/piece.
- Disposable non-woven masks robust Medical nursing masks. ROBUST MEDICAL LIMITED. The price is about 0.8RMB/piece.
- Glucono-delta-lactone Anhui Xingzhou Pharmaceutical Food Co., Ltd., food additive.
- Grape seed extract proanthocyanidins: Xi'an Rongzhen Biotechnology Co., Ltd., proanthocyanidin content 95% OPC (UV), [CAS No]: 84929-27-1.
- Lemon oil Guangzhou Huixin Biotechnology Co., Ltd., [CAS No]: 8008-56-8, the main component is limonene.
- 3M TM 8246 Occupational Protective Mask R95 activated carbon anti-particle mask, used for acid gas and oily/non-oily particle protection, Minnesota Mining and Manufacturing.
- the retail price is about 28RMB/piece.
- 3M TM 8247 Occupational Protective Mask R95 activated carbon anti-particle mask, used for organic vapor odor and oily/non-oily particle protection, Minnesota Mining and Manufacturing. Retail price is about 28RMB/piece.
- composition A aqueous solution
- Composition B aqueous solution
- composition C aqueous solution
- composition D aqueous solution
- composition A aqueous solution
- composition B aqueous solution
- 6 mg of glycerin aqueous solution
- 6 mg of glycerin aqueous solution
- Ethyl hydroxyphenyl ester stir evenly. After the above solution is evenly infiltrated into the base material of the mask, it is dried in a nitrogen atmosphere to obtain mask A.
- 102 represents the ear strap of the mask
- 101 represents the base material of the mask, which has the above composition adsorbed thereon.
- composition A aqueous solution
- composition B aqueous solution
- glycerin aqueous solution
- 6 mg of ethyl hydroxyphenyl ester 6 mg
- the above solution is uniformly infiltrated into the base material of the mask, it is dried in a nitrogen atmosphere to obtain the base material 101 of mask B.
- the activated carbon layer 201 is fixed on the outside of the base material 101 by hot melting to obtain the mask B.
- 102 represents the ear strap of the mask
- 101 represents the base material of the mask
- 201 represents the activated carbon layer of the mask.
- a melt-blown cloth filter layer can also be inserted between the activated carbon layer 201 and the base material 101 to block fine particles. Since peracetic acid is an organic vapor, adding an activated carbon layer to mask B can effectively strengthen the physical adsorption of the mask, thereby achieving a combined filtration effect of physical adsorption and chemical adsorption neutralization.
- the above solution is evenly infiltrated into the base material of the mask, it is dried in a nitrogen atmosphere to obtain the second base material 301 of the mask C.
- Polyester filter cotton with a thickness of 3 mm is used as the middle isolation layer 302. Arrange the first base material 101, the middle isolation layer 201 and the second base material 301 in order from the outside to the inside, and prepare a multi-layer mask C by hot melting.
- 102 represents the ear strap of the mask
- 101 represents the first base material of the mask
- 302 represents the second base material
- 301 represents the second base material. Since the active substances in the first base material 101 and the second base material 302 need to work in different pH environments, the active substances in the first base material 101 are relatively stable in a weakly acidic environment of pH 5.0-6.2, while peroxidation Hydrogenase can maximize the catalytic decomposition of hydrogen peroxide in a pH 7.0 environment. Therefore, the middle isolation layer 302 can effectively isolate the active substances of the two base materials, and the use of polyester filter cotton will not affect the air circulation. . In addition, arranging the second base material 301 on the inside close to the person's face can make the second base material 301 have a relatively high temperature, which is more conducive to the decomposition of hydrogen peroxide by catalase.
- the measured pH of 5000ppm peracetic acid disinfectant is 2.1, which is highly acidic and exceeds the color development conditions of peroxide test paper. It needs to be neutralized by acid and alkali before using test paper to detect the peroxide concentration.
- the neutralization product of peracetic acid and acetylcysteine can cause the peroxide detection test paper to fade, and the maximum value of the color change at the moment when the test paper is put into the solution is taken as the reading.
- Peroxide disinfectants are more oxidizing than chlorine-containing disinfectants and can cause the chlorine test paper to turn brown and then further oxidize, causing the brown product to fade. Therefore, the chlorine test paper cannot be directly put into the reaction system.
- the reaction between glycine and glutaraldehyde can be carried out at room temperature.
- the reaction condition is pH>5.0.
- a yellow product is usually generated within 5-10 seconds and gradually becomes darker.
- the detection range of currently commercialized glutaraldehyde test paper is 0 -3%, most are also glycine colorimetric methods. Since the color reaction of the test paper is also yellow-orange, the test paper reading is easily disturbed.
- reaction rate constant K 2 is 1.0 ⁇ 10 5 M -1 s -1 , which is much lower than the cysteine side chain K 2 of 3.0 ⁇ 10
- the reaction rate constant is 7 M -1 s -1 , so this slow neutralization effect cannot be observed in titration experiments.
- aqueous solutions of vitamin C and N-acetylcysteine can effectively neutralize hypochlorous acid in chlorine-containing disinfectants, while aqueous solutions of glycine can effectively neutralize glutaraldehyde-containing disinfectants. agent.
- the moisture absorbing agent has the function of absorbing water and can change the composition into a moist state or a solution state, that is, corresponding to the vitamin C aqueous solution, N-acetylcysteine aqueous solution and Glycine aqueous solution, while the moisture attractant will not participate in the reaction between the above compounds and chlorine, and will not affect the efficiency of the neutralization reaction.
- the above results confirm that the compounds of the present invention can effectively adsorb and neutralize chlorine-containing disinfectants, peroxide-containing disinfectants and glutaraldehyde-containing disinfectants, and can adsorb and neutralize the irritating gases volatilized by the above-mentioned disinfectants. .
- (II) Prepare the disinfectant according to the medical disinfection concentration in Table 1, transfer 5 mL of disinfectant into a 100 mL iodine bottle through a pipette, and slightly add iodine to the bottle to evaporate the disinfectant.
- the mask A of the invention is placed in the central area of the above-mentioned iodine bottle.
- the front and back sides of the central area of the mask are respectively pasted with test paper with a length of about 10mm.
- the two test papers are 3-5mm apart to facilitate the passage of airflow.
- the test paper used is chlorine test paper; for chlorine dioxide disinfectant, the test paper used is chlorine test paper Chlorine oxide test paper; for glutaraldehyde disinfectant, the test paper used is glutaraldehyde test paper.
- the mask of the present invention can effectively absorb and neutralize irritating gases in various disinfectants.
- mask A is adsorbed with the composition of the present invention, which contains bioactive ingredients such as vitamin C, N-acetylcysteine, glycine, etc. Therefore, the above qualitative experiment can also confirm that it is effective against irritating gases (such as those in disinfectant solutions). irritating gases), the composition of the present invention has excellent absorption capacity. In addition, the composition of the present invention can absorb and neutralize irritating gases more effectively than vitamin C itself.
- bioactive ingredients such as vitamin C, N-acetylcysteine, glycine, etc. Therefore, the above qualitative experiment can also confirm that it is effective against irritating gases (such as those in disinfectant solutions). irritating gases), the composition of the present invention has excellent absorption capacity. In addition, the composition of the present invention can absorb and neutralize irritating gases more effectively than vitamin C itself.
- the mask A of the present invention into a 250 ml conical flask, and add 100 mL of water to the conical flask. Stir the water in the above-mentioned Erlenmeyer flask to fully dissolve the components of mask A in the water to obtain the mask extract. Take out 10mL of mask extract and perform a titration experiment according to the method in Table 1 to determine the content of active substances in the mask. The measurement results are magnified 10 times to obtain the content of active substances in the mask. The test results are shown in Table 2.
- the above results can confirm that the mask of the present invention can effectively absorb and neutralize irritating gases in various disinfectants.
- mask A adsorbs the composition of the present invention, so the above results can also confirm that the composition of the present invention has excellent absorption capacity for irritating gases (such as irritating gases in disinfectant solutions).
- the composition of the present invention can absorb and neutralize irritating gases more effectively than vitamin C itself.
- the mask turns yellow within a few hours after being exposed to the air. After the tester wears the above mask A, the tester can smell a slightly faint disinfectant smell, but the smell is not irritating.
- test paper on the outside of the mask changes color, but the test paper on the inside of the mask does not change color.
- the mask of the present invention still has the ability to absorb disinfectants and neutralize irritating gases, and the mask of the present invention has excellent stability.
- mask A is adsorbed with the composition of the present invention, which contains bioactive ingredients such as vitamin C, N-acetylcysteine, glycine, etc., each of which has different reducing properties or reactivity. Even if it is left standing in the air for a long time, For a long time (such as 14 days), the composition can still absorb and neutralize irritating gases (such as irritating gases in the air or in disinfectants). Therefore, the above results can also confirm that the composition of the present invention has excellent stability. sex. In particular, the combination of the invention has significantly improved stability compared to vitamin C itself.
- the above results can confirm that even if it is oxidized and discolored by air, the mask of the present invention still has the ability to absorb disinfectants and neutralize irritating gases, and the mask of the present invention has excellent stability.
- mask A adsorbed the composition of the present invention, so the above results can also confirm that the composition of the present invention has excellent stability.
- the combination of the invention has significantly improved stability compared to vitamin C itself.
- the microbial limits of non-sterile masks are: bacteria ⁇ 100CFU/g, Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, hemolysis Sexual streptococci and fungi shall not be detected.
- mask A is unpacked in a class 100 ultra-clean bench, extracted with 0.9% sodium chloride injection, and the extract is added to agar culture medium.
- mask A was placed in an environment with a relative humidity of 70-95% and a temperature of 25-35°C for two weeks, then soaked in water to dilute the preservative, and then sampled and operated in an open environment to observe The impact of environmental bacteria on masks.
- the test results are shown in Table 4.
- the microbial index of the mask not only meets the requirements of industry standards, but also inhibits environmental microorganisms.
- the cultured environmental colony microorganisms are mainly Paenibacillus urinae, which can produce spores and is resistant to harsh environments (such as preservatives), so it grows in low-concentration preservative environments.
- this bacterium is a non-pathogenic background microorganism, mostly coming from animal urine.
- reaction end point of glycine (or other amino acids) neutralizing glutaraldehyde disinfectant is determined by the following method:
- step (4) Use sodium hydroxide aqueous solution to titrate the mixed solution in step (4) until the pH is 8.2;
- step (7) Cool the mixed liquid in step (6) and measure the pH value of the mixed liquid;
- step (9) Dilute the mixed solution of step (8), and titrate the mixed solution of step (8) using sodium hydroxide aqueous solution to a pH of 8.2;
- step (10) Use sodium hydroxide aqueous solution to titrate the mixed solution in step (10) to pH 9.2, and record the volume V 2 (mL) of the titrant;
- V 1 represents the volume of sodium hydroxide standard titration solution consumed after formaldehyde is added to the sample diluent for measurement, in milliliters (mL);
- V 2 represents the volume of sodium hydroxide standard titration solution consumed after adding formaldehyde in the reagent blank test, in milliliters (mL);
- C NaOH represents the concentration of sodium hydroxide standard titration solution, in moles per liter (mol/L);
- MW amino acid represents the molar mass (molecular weight) of the amino acid, in grams per mole (g/mol);
- the amino acid used in the embodiment of the present invention is glycine, and its molar molecular weight is 75.07g/mol.
- Table 5 shows the end-point test results of the reaction between glutaraldehyde disinfectant and glycine.
- the analysis method of the present invention can accurately obtain the stoichiometric point of the material consumption ratio of the neutralization reaction between glutaraldehyde and amino acid substances, that is, accurately obtain the end point of the neutralization reaction and obtain the amount of consumed amino acids.
- the protective limit performance and color rendering performance of the mask of the present invention were tested by the following methods.
- the color rendering performance of the mask is similar to the mask protective limit performance experiment. The difference is:
- 3M TM occupational exposure protective mask was used as a comparative example.
- Paste a piece of glutaraldehyde test paper on the inner surface of mask D, and wrap the test paper with waterproof and breathable material (such as the blue waterproof layer of a medical mask) to prevent it from being contaminated by the active ingredients of mask D.
- Set the water bath to about 95°C and place a 100ml evaporating dish on the water bath to fully preheat.
- Use a pipette to measure 25 ml of 2 wt% glutaraldehyde disinfectant solution and add it to the preheated evaporating dish.
- the comparative example uses 3M TM 8247 organic vapor and particle protective mask, which conducts the above experiments under the same conditions.
- the mask was placed in a drying dish and vacuum dried for more than 24 hours before the test.
- the experimental method for the protective performance of hypochlorous acid chlorine-containing disinfectant is similar to the protective performance test of glutaraldehyde disinfectant. The difference is that a chlorine-containing disinfectant with an effective chlorine concentration of 30,000 ppm is used, and the test paper used is a chlorine test paper. Set the water bath at about 45°C and heat and fumigate for 4 hours. For the comparison example, 3M TM 8246 acid gas and particle protective mask was used.
- the experimental method for the protective performance of peracetic acid disinfectant is similar to the test for the protective performance of chlorine-containing disinfectant. The difference is that 15000 ppm peracetic acid disinfectant is used, and the test paper is peracetic acid test paper. Set the water bath at about 45°C, heat and fumigate for 6 hours, then close the water bath and use the residual heat to leave it for 17.5 hours. For the comparison example, 3M TM 8246 acid gas and particle protective mask was used.
- the experimental method for the protective performance of hydrogen peroxide disinfectant is similar to the protective performance test of chlorine-containing disinfectant. The difference is that 30,000 ppm hydrogen peroxide disinfectant is used, and the test paper is a hydrogen peroxide test paper. Set the water bath at about 45°C, heat and fumigate for 6 hours and then close the water bath. For the comparison example, 3M TM 8246 acid gas and particle protective mask was used.
- test method for the protective performance of chlorine dioxide disinfectant
- the test method is similar to the protective performance test of chlorine-containing disinfectant. The difference is that 20,000 ppm chlorine dioxide disinfectant is used, and the test paper is hydrogen peroxide test paper. Set the water bath at about 45°C, heat and fumigate for 6 hours, then close the water bath and use the residual heat to leave it for 18 hours.
- 3M TM 8246 acid gas and particle protective mask was used.
- the liquid used for fumigation in the evaporating dish can also be added by gradual titration until the test paper changes color, so as to simulate the situation of mask D after repeated use. Compared with the comparative example Compare.
- 3M TM masks are used as a comparative example.
- the specific masks used include 3M TM 8246 type masks and 3M TM 8247 type masks.
- the above examples can confirm that the mask D of the present invention is significantly better than the comparative example in protecting the volatile gases of trichloroisocyanuric acid, chlorine dioxide, and glutaraldehyde disinfectant.
- the mask D of the present invention is equivalent to the comparative example.
- the protection against hydrogen peroxide the mask D of the present invention has a relatively long-lasting effect.
- the test paper on the mask D did not change color until 6 hours after the experiment was carried out.
- the above results show that in the environment of the above-mentioned high concentration of irritating gas, the mask of the present invention has strong protective ability.
- the inventor unexpectedly discovered that due to the use of amino acids in the formula of the mask composition, the mask of the present invention will produce a specific discoloration reaction under the irritating gas environment of high concentrations of disinfectants, that is, under the irritating gas environment of different disinfectants, After repeated use in the environment, the floor mask of the present invention will produce different discoloration reactions.
- the mask of the present invention will turn red after repeated use.
- the mask of the present invention will turn dark yellow after repeated use.
- glutaraldehyde disinfectant the mask of the present invention will turn dark brown after repeated use.
- the active ingredients in the mask will oxidize and the mask will turn yellow.
- the degree of color change mentioned above is related to the concentration of volatile gases in the disinfectant and the use time of the mask. Among them, the degree of color change can also reflect the time that the mask of the present invention can continue to be used. For example, the deeper the color change of the mask, the shorter the time the mask of the present invention can continue to be used.
- the mask of the present invention can not only efficiently absorb and neutralize irritating gases in various disinfectants, but can also perform a discoloration reaction according to the state of the active ingredients in the mask, and timely reflect how long the mask can continue to be used.
- the mask of the present invention can not only effectively absorb and neutralize irritating gases in disinfectants, but also has additional heat dissipation properties. Among them, the heat dissipation performance is specifically achieved through the following methods.
- the tester wears a mask and takes a thermal image temperature measurement
- the tester takes off the mask and takes a thermal image temperature measurement.
- the heat is blocked by the mask and transferred to the facial skin, so the facial skin in contact with the mask has higher humidity and temperature.
- the above steps reflect the impact of different masks on the tester's facial temperature by measuring the temperature of the tester's face when wearing and taking off the mask.
- the mask A of the present invention is used as an example, and the disposable medical non-woven nursing mask and cotton mask are used as a comparative example to detect the above temperatures respectively.
- Figure 5-a shows the thermal image when wearing a disposable medical non-woven nursing mask
- Figure 5-b shows the thermal image of the facial skin taken at the moment when the above mask is taken off
- Figure 6-a shows the thermal image when wearing a cotton mask.
- Thermal image Figure 6-b shows the thermal image of facial skin taken at the moment when the above mask is taken off
- Figure 7-a shows the thermal image when wearing the mask A of the present invention
- Figure 7-b shows the thermal image taken at the moment when the above mask is taken off Thermal image of facial skin.
- the skin surface temperature of the part of mask A that is in contact with the skin is significantly lower than that of the non-contact part.
- the mask of the present invention not only has the above-mentioned ability to absorb and neutralize irritating gases, but also has obvious heat dissipation performance.
- the maximum temperature of the tester's facial skin is 36.6°C.
- the above-mentioned temperature is close to the body temperature of the human body, so the wearer will not feel stuffy when wearing the mask of the present invention.
- the temperature of the facial skin will not increase. Therefore, the mask of the present invention has excellent heat dissipation performance.
- the composition of the present invention can be stored in a vacuum spray bottle with a piston structure at the bottom, or in a traditional spray bottle with a straw as shown in Figure 8.
- 1001 is a transparent plastic bottle with a wall thickness of 0.4-5mm
- 1002 is a cock spray button
- 1003 is a rotatable nozzle
- 1004 is a suction tube
- 1005 is a liquid sealing agent, with To isolate the composition solution and air
- 1006 is the composition solution of the present invention.
- Such a packaging structure can reduce the contact area between the composition and air.
- the capacity of the spray bottle is 20 ml
- the wall thickness is 1.2 mm
- the liquid sealant uses 0.6 ml of liquid paraffin
- the liquid sealant thickness is 1.5 mm.
- approximately 0.094ml of liquid can be sprayed out each time the key is pressed.
- a vacuum spray bottle with a piston AS at the bottom can also be used to store the composition solution of the present invention.
- the composition solution is a 2.7% (W/V) vitamin C solution and a composition solution of mask E (see Example 2).
- the storage environment is an indoor room with a north-facing window, no direct sunlight, but with natural light and fluorescent indoor lighting.
- the half-life of an active ingredient such as a vitamin).
- k represents the rate constant (d -1 )
- C 0 represents the initial concentration
- C represents the concentration at t
- t-time is days (d)
- t 1/2 represents the half-life.
- the formulas of vitamin C solution or mask E were stored in different ways.
- plastic bottles can be used to store vitamin C solution.
- a plastic bottle can be used to store the vitamin C solution, and a liquid sealing agent can be added to the plastic bottle for further sealing.
- an AS vacuum spray bottle can be used to store the formula of mask E; wherein the formula of mask E contains grape seed extract (proanthocyanidins).
- test results of the above examples can confirm that using the container shown in Figure 8 to store the composition solution of the present invention, the composition of the present invention can be stored for a long time without deterioration, with a half-life of 443-3253 days, up to 3253 days. .
- the inventor unexpectedly discovered that because the grape seed extract in the formula of Mask E has a maximum absorbance at 546nm, it can absorb blue-violet light, thus exhibiting the effect of a brown sunscreen.
- This composition formula also greatly extends the shelf life of light-sensitive vitamin C, with a half-life of up to 3253 days. This makes the composition of the present invention have significant industrial applicability and commercial value.
- the composition of the present invention obviously has significantly better stability.
- Preserving the composition of the present invention in the above manner not only extends the storage time of the composition of the present invention, but also allows the composition of the present invention to be accessed at any time. It also provides a method for quickly preparing the mask of the present invention, which includes:
- step (2) Spray the composition liquid of step (1) onto the inside and/or outside of the mask by spraying.
- the mask used in step (2) can be a commercially available disposable mask or a cotton mask, etc.
- the spray bottle body 1001 is tilted, and the rotatable nozzle 1003 is adjusted to a distance of about 5-10cm from the mask D, and the front and back sides of the cotton mask are Spray the composition liquid evenly, press the spray button 17 times each, a total of 34 times, approximately 3.2 ml of the composition liquid can be sprayed, thereby quickly completing the preparation of the occupational exposure protective mask D.
- the spray bottle containing the composition solution of the present invention can be stored separately from the ordinary mask.
- the composition of the present invention can be immediately sprayed on the inside and/or outside of the ordinary mask to obtain the mask of the present invention.
- the mask can be stored in a dry environment and sprayed with the solution only when used. Since the middle layer of existing masks is mostly made of polypropylene melt-blown cloth and electret electrostatic process, such masks must be stored in an extremely dry environment to avoid loss of static charge.
- the above method can not only quickly obtain the mask of the present invention, but also store the composition and the mask separately under different conditions to further extend the storage time of the composition and the mask.
- Example 13 Disinfection effect of the composition of the present invention and its compatibility with alcohol-based disinfectants
- the present invention designs relevant tests to detect the performance of the composition and alcohol-based disinfectants. compatibility. Among them, the disinfection effect of the composition and its compatibility with alcohol-based disinfectants were tested by the following methods.
- step (3) Shake the container in step (3) for 5 minutes, and then observe the protein denaturation and precipitation effect.
- compositions 1 and 2 were controlled to be about 5.5-6.2.
- composition 1 has good protein protection effect.
- Composition 1 is mixed with disinfectant alcohol (Experiment B)
- the effect of protein denaturation and precipitation can still be achieved, so Composition 1 will not reduce the effect of disinfectant alcohol.
- composition 2 water-propylene glycol solvent, containing protein coagulant and plant extract
- egg white egg white
- composition 2 can be used to slowly inhibit the biological activity of microbial surface proteins.
- disinfectant alcohol experiment D
- protein coagulant and plant extract are added to the composition, the protein denaturation and precipitation effect can still be achieved.
- composition 2 when Composition 2 is used in combination with disinfectant alcohol, the addition of protein coagulants and plant extracts will not only not affect the effect of disinfectant alcohol, but can also work synergistically with disinfectant alcohol to quickly inhibit protein activity while also sustaining the effect. Inhibit protein activity, thereby achieving stronger disinfection effect and achieving long-term disinfection.
- the composition of the present invention propylene glycol can be used as a moisture absorbing agent, and the moisture absorbing agent can make the composition form a solution state after absorbing moisture in the air.
- the water-propylene glycol system in this embodiment corresponds to the aqueous composition solution system of the present invention. Therefore, by adding protein coagulants and plant extracts, the composition of the present invention will not only not affect the disinfection effect of disinfectant alcohol, but can also perform collaborative disinfection, quickly inhibit protein activity and achieve long-term disinfection, achieving stronger and lasting disinfection. Effect.
- moisture-absorbing agents such as propylene glycol
- plant extracts such as grape seed extract
- Adding the above-mentioned plant extracts and moisture attractants can reduce the use of alcohol-based disinfectants, thereby reducing their irritation to the skin.
Abstract
La présente invention concerne une composition, comprenant, sur la base du poids total de la composition : (A) environ 0,1 à 99 % en poids d'un bio-adsorbant, et (B) environ 0,0001 à 99 % en poids d'un agent hygroscopique. La présente invention concerne également un substrat, qui comprend la composition. La présente invention concerne en outre un matériau multicouche A et un matériau multicouche B, qui comprennent le substrat. La présente invention concerne également un masque, qui comprend le substrat ou les matériaux multicouches.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2022/092725 WO2023216238A1 (fr) | 2022-05-13 | 2022-05-13 | Composition et son utilisation, et matériaux la comprenant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2022/092725 WO2023216238A1 (fr) | 2022-05-13 | 2022-05-13 | Composition et son utilisation, et matériaux la comprenant |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023216238A1 true WO2023216238A1 (fr) | 2023-11-16 |
Family
ID=88729512
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2022/092725 WO2023216238A1 (fr) | 2022-05-13 | 2022-05-13 | Composition et son utilisation, et matériaux la comprenant |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2023216238A1 (fr) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991012826A1 (fr) * | 1990-02-27 | 1991-09-05 | Allergan, Inc. | Compositions detruisant le peroxyde d'hydrogene et procedes d'utilisation de cette composition |
US5312588A (en) * | 1990-02-27 | 1994-05-17 | Allergan, Inc. | Hydrogen peroxide destroying compositions and methods of making and using same |
US6022732A (en) * | 1997-04-09 | 2000-02-08 | Allergan | Hydrogen peroxide destroying compositions and methods of using same |
US20110305736A1 (en) * | 2010-06-10 | 2011-12-15 | Dr. Suwelack Skin & Health Care Ag | Stratiform Perforated Biomatrices |
CN107126643A (zh) * | 2017-06-16 | 2017-09-05 | 王宇 | 一种复合材料层及含有该复合材料层的鼻孔即时贴 |
CN112493575A (zh) * | 2020-09-18 | 2021-03-16 | 安徽云飞芳植生物科技有限公司 | 新型口罩制作方法 |
-
2022
- 2022-05-13 WO PCT/CN2022/092725 patent/WO2023216238A1/fr unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991012826A1 (fr) * | 1990-02-27 | 1991-09-05 | Allergan, Inc. | Compositions detruisant le peroxyde d'hydrogene et procedes d'utilisation de cette composition |
US5312588A (en) * | 1990-02-27 | 1994-05-17 | Allergan, Inc. | Hydrogen peroxide destroying compositions and methods of making and using same |
US6022732A (en) * | 1997-04-09 | 2000-02-08 | Allergan | Hydrogen peroxide destroying compositions and methods of using same |
US20110305736A1 (en) * | 2010-06-10 | 2011-12-15 | Dr. Suwelack Skin & Health Care Ag | Stratiform Perforated Biomatrices |
CN107126643A (zh) * | 2017-06-16 | 2017-09-05 | 王宇 | 一种复合材料层及含有该复合材料层的鼻孔即时贴 |
CN112493575A (zh) * | 2020-09-18 | 2021-03-16 | 安徽云飞芳植生物科技有限公司 | 新型口罩制作方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7858124B2 (en) | Anti-bacterial, anti-virus, and anti-fungus composition, its preparation and use | |
US7976876B2 (en) | Anti-bacterial, anti-virus, and anti-fungus composition, its preparation and use | |
JP2012072134A (ja) | 抗菌用銀イオン生成液、その液から生成された銀イオン抗菌液及びその抗菌液を生成する生成方法 | |
US20210178106A1 (en) | Nitric oxide generating systems for inhalation | |
CN108743702A (zh) | 一种抗霾毒喷剂及其制备方法 | |
Gottardi | Iodine as disinfectant | |
CN109846113A (zh) | 一种可自提供一氧化氮的口鼻卫生用品 | |
WO2023216238A1 (fr) | Composition et son utilisation, et matériaux la comprenant | |
JP2024052763A (ja) | 一酸化窒素発生システム | |
JP2005218613A (ja) | マスク | |
CN105381454B (zh) | 一种含海藻糖的鼻腔润湿剂 | |
RU2644316C1 (ru) | Профилактическая лицевая маска для противомикробной защиты при заболеваниях верхних дыхательных путей, передающихся воздушно-капельным путем | |
CN116471936A (zh) | 产生稳定地包含游离的有效氯物质和过氧化物的组合物的方法和用途 | |
JPH02116302A (ja) | 防臭殺菌性靴中敷 | |
CN102283450A (zh) | 银离子灭菌消毒口罩及其制造方法 | |
Lachenmeier | Antiseptic drugs and disinfectants with experience of the second year of COVID-19 pandemic-related side effects | |
CN110272023A (zh) | 一种全天候室内除醛装置及其使用方法 | |
Chooi et al. | COVID 19: The safety profile of common disinfectants used for sanitization | |
EP1576880A1 (fr) | Composition antibactérienne, antivirale et antifongique, sa préparation et utilisation | |
JPH0639367B2 (ja) | 脱臭及び殺菌用組成物 | |
Shambhavi et al. | BT100, a three-in-one, multipurpose disinfecting, deodorizing, and air-cleaning solution with an effective, gradual, and continuous gaseous chlorine dioxide-releasing substance | |
US20230110299A1 (en) | Hygiene Base Composition, and Production Method and Application Method Thereof | |
CN106472560A (zh) | 一种氧气湿化液抑菌剂 | |
TW202333755A (zh) | 用於預防及治療細菌及病毒感染之呼吸道病症的水溶液醫藥組合物及其行動防護給藥裝置 | |
CN110583690A (zh) | 一种室内空气净化凝胶及其使用方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22941192 Country of ref document: EP Kind code of ref document: A1 |